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The ~i-adrenergic agonist, ractopamine, stimulates muscle hypertrophy and 
increases lean bod composition in the pig. Increases in protein synthetic rate, Y 
changes in muscle fiber type, and increases in the pre-translational expression of 
skeletal muscle-specific genes in skeletal muscle have been documented after 
treatment with ractopamine. These effects may be the accumulation of changes in 
enzymatic activity, substrate utilization, andlor gene transcription. This research 
addressed ractopamine's capacity to alter gene expression. In the first study, the 
transcriptional responsiveness of the porcine skeletal a-actin promoter was 
evaluated. In porcine myotubes, ractopamine stimulated the accumulation of 
skeletal a-actin mRNA. However, the previously cloned full-length porcine skeletal 
a-actin promoter was unresponsive to ractopamine treatment. It is possible that a 
novel mechanism regulates the accumulation of skeletal a-actin mRNA, possibly via 
an unidentified regulatory element within, or adjacent to, the gene's locus. 
Alternatively, skeletal a-actin mRNA stability could be enhanced in response to 
ractopamine. In the second study, the suppression subtractive hybridization 
technique was used to identify differentially expressed genes in porcine skeletal 
muscle after feeding ractopamine to pigs for three days. From this initial screen, 
nine genes and one expressed sequence tag were tentatively identified. Further 
analysis confirmed that ractopamine increased the steady state mRNA abundance 
of calmodulin-1 by approximately two-fold. This is the first study to implicate 
calcium-modulated proteins and calcium signaling as potentially being involved in 
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the cellular response to ractopamine in porcine skeletal muscle. Future 
investigations should address the physiological significance of increased calmodulin 
expression, as calcium/calmodulin dependent proteins have been implicated in both 
muscle hypertrophy and muscle fiber type transition. 
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CHAPTER 1. GENERAL INTRODUCTION 
Introduction 
The ability to manipulate growth and protein accretion in domestic livestock 
species is important to the sustainability of animal agriculture. Livestock producers 
constantly seek to increase the output of nutritious meat products while improving 
production efficiency. Historically, progress in this regard has relied on intensifying 
genetic selection, developing better nutrition programs, and adopting improved 
production systems. More recently, producers have begun to appreciate the 
anabolic enhancing capacity of growth promotants, such as antimicrobials, growth 
factor analogues, and ~i-adrenergic agonists. In lieu of considerable research into 
the efficacy and potential economic benefit, the livestock industry stands to benefit 
from the future integration of such compounds into modern production schemes. 
When incorporated into livestock diets, ~i-adrenergic agonists improve lean 
carcass composition, dressing percentage, growth rate, and growth efficiency 
without adversely affecting meat quality in most species. One class of synthetic ~i-
adrenergic agonists, the phenethanolamines, has a profound effect on skeletal 
muscle mass. Increased rates of protein synthesis and/or decreased rates of protein 
degradation are hallmark responses to phenethanolamines. A sustained increase in 
net protein accretion ultimately leads to skeletal muscle hypertrophy and increased 
muscle mass. 
Our current understanding of the molecular processes stimulated by 
phenethanolamines, as well as other classes of ~i-adrenergic agonists, is limited. 
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Phenethanolamines, such as ractopamine and clenbuterol, are high affinity ligands 
for the ~i-adrenergic receptors, which are present on cellular membranes in skeletal 
muscle and other tissues. Several signal transduction pathways may mediate 
cellular response to ~i-adrenergic agonists. However, few studies have sought to 
directly clarify the specific mechanisms that lead to hypertrophy in treated livestock. 
The future development of targeted growth promotants for use in animal agriculture 
may benefit from the elucidation of the molecular mechanisms by which 
phenethanolamines initiate and maintain long-term anabolic affects in skeletal 
muscle. The identification of regulatory mechanisms that control gene expression in 
response to ractopamine would provide a framework to address this question. 
This project investigated the effect of ractopamine on muscle specific gene 
expression in the pig. In the first study, the hypothesis that ractopamine directly 
regulates the expression of the porcine skeletal a-actin gene via cis-acting DNA 
elements was tested. The observed increase in pre-translational expression of 
skeletal a-actin in pigs treated with ractopamine parallels the observed increase in 
myofibrillar protein expression and skeletal muscle hypertrophy. Therefore, 
identifying regulatory mechanisms that control the expression of this gene should 
provide insight into the mechanisms by which ractopamine induces skeletal muscle 
hypertrophy. In a later study, we identified differentially expressed genes by a 
polymerase chain reaction (PCR) based cDNA subtraction technique known as 
suppression subtractive hybridization. Polyadenylated mRNA was isolated from the 
longissimus dorsi muscle of pigs fed ractopamine for seventy-two hours and 
compared to controls. Using this technique, a normalized cDNA library is generated 
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from mRNA transcripts and amplified by PCR. Exponentially amplified cDNA 
amplicons may correspond to genes regulated by ractopamine in treated skeletal 
muscle. Genes expressed in response to three days of ractopamine stimulation in 
skeletal muscle were identified by homology after comparison of the subcloned 
amplicon sequence to public databases. Presumably, these genes are regulated by 
ractopamine and are required for sustained muscle hypertrophy and/or alterations in 
myosin heavy chain isoform content. The cumulative findings of this project will 
provide direction for future studies designed to explain the molecular mechanisms by 
which R-adrenergic agonists enhance lean body composition. 
Thesis Organization 
This thesis presents the author's research in the alternative format. The first 
chapter contains a general introduction and a review of the relevant scientific 
literature. The second chapter is a manuscript prepared for submission to the 
Journal of Animal Science, which details the author's work that addresses the 
transcriptional regulation of the skeletal a-actin gene in response to ractopamine in 
an in vitro model. The third chapter is a manuscript prepared for submission to the 
Journal of Animal Science, which details the procedures used to putatively identify 
genes that are differentially expressed in response to ractopamine stimulation in 
vivo. The final chapter discuses the results obtained by the author as they pertain to 
our understanding of skeletal muscle hypertrophy and increased protein accretion in 
response to phenethanolamine treatment. 
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Review of Relevant Literature 
Catecholamines: Nature's ,~3-Adrenergic Receptor Agonists 
Before the turn of the twentieth century, George Oliver and Edward Albert 
Schafer made the seminal observation that adrenal preparations increased blood 
pressure (Oliver &Schafer, 1894). This established, for the first time, that the 
adrenal medulla was potentially responsible for hormonal action of physiological 
consequence. From similar preparations, Abel (1898) isolated the hormone 
responsible for these effects, which he referred to as epinephrine. Cannon and 
colleagues characterized many of the biological actions of epinephrine (Cannon, 
1940), and coined the phrase "fight or flight hormone" to describe the ability of 
epinephrine to maintain physiological homeostasis during stress. A second 
hormone, norepinephrine, which is nearly indistinguishable from epinephrine, was 
determined to be of medullary origin (Goldenberg et al., 1949; von Euler & Harnberg, 
1949). Therefore, Oliver, Schafer, Cannon, and others demonstrated not only the 
individual action of epinephrine, but also the combined synergistic affects of 
epinephrine and norepinephrine. 
Epinephrine and norepinephrine, structurally classified as catecholamines, 
are the principle hormones of the autonomic nervous system and mediate a diverse 
array of physiological processes. Norepinephrine is the major neurotransmitter in 
the sympathetic nervous system and is the more abundant Catecholamine in the 
peripheral circulation. Both norepinephrine and epinephrine act as hormones when 
secreted by the adrenal medulla (Ganong, 2001). In response to stress, epinephrine 
initiates catabolism of body energy reserves through increased rates of liver 
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glycogenolysis, white adipose lipolysis, and brown adipose thermogenesis. The 
catecholamines support skeletal and cardiac muscle hypertrophy under some 
physiological conditions, but this anabolic affect is limited. In addition, cardiac 
contractility, vasoconstriction, bronchodilation, and gastric reflexes are physiological 
processes regulated by norepinephrine and epinephrine. While this is not an all-
inclusive list, the diverse mechanisms activated in response to catecholamine 
release appear to be of evolutionary significance, as they are highly conserved 
across species. 
Adrenergic Receptors and Signal Transduction 
Cellular responses to norepinephrine and epinephrine are initiated when they 
bind to two distinct classes of receptors: the a- and ~i-adrenergic receptors. Both of 
these catecholamines signal through adrenergic receptors, albeit with different 
affinities. Norepinephrine has greater affinity for the a-adrenergic receptors, 
whereas epinephrine has higher affinity for the ~i-adrenergic receptors (Ganong, 
2001). Assigned initially by pharmacological properties and, later, by identification of 
different encoding genes and protein products, the a-adrenergic receptors are 
currently divided into nine subtypes (a1 A, a1 B, a1 D, a1 L, a2A, a2B, a2C, a2D, and 
a2A/D) (Civantos & Aleixandre de Artinano, 2001); only three subtypes (~i1, ~i2, and 
X33) comprise the ~i-adrenergic receptor family (Wallukat, 2002). 
The adrenergic receptors belong to a larger class of structurally similar seven 
transmembrane-domain proteins, or G-protein coupled receptors. As the name 
implies, these receptors couple to heterotrimeric guanine nucleotide exchange 
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proteins (G-proteins) that serve as signal transducers to activate or inhibit other 
proteins. The assortment of physiological responses to catecholamines is a net 
result of the combined diversity of the adrenergic receptors, their multiple associated 
G-proteins, and proteins regulated by G-proteins through second messenger 
molecules, such as cyclic adenosine monophosphate (cAMP), diacylglycerol (DAG), 
and inositol 1,4,5-triphosphate (IP3) (Pierce et al., 2002). lJltimately, these second 
messengers regulate effector proteins involved in ion transport, gene transcription, 
and signal transduction cascades, which adds to the complexity of the cellular 
response to ligand activation of the membrane-associated receptor. Consequently, 
our knowledge of the molecular mechanisms regulated by this class of receptors has 
yet to be exhausted. 
Catecholamine Regulation of Adipose Metabolism 
In all mammals, white adipose tissue is the major storage site of neutral fat 
(Ganong, 2001). Adipose tissue hypertrophies when energy exceeds metabolic 
demand. Excess dietary fatty acids and glucose are stored in adipocytes as 
triglycerides through the biochemical process of lipogenesis. In a fed state, 
lipogenesis is predominately regulated by insulin, which is produced in pancreatic B 
cells and stimulates glucose uptake. During fasting, lipolysis causes atrophy, or 
regression, of adipose tissue. Lipases catalyze the breakdown of triglycerides to 
glycerol and fatty acids, which then are available for ~3-oxidation and ATP synthesis 
in peripheral tissues. The catecholamines regulate both lipolysis and lipogenesis via 
distinct and well-defined mechanisms. 
Catecholamine-induced lipolysis represents a classical signal transduction 
pathway regulated by catecholamines. While all three ~i-adrenergic receptor 
subtypes activate this pathway, the R3-adrenergic receptor may be the most 
efficacious in adipose because this subtype is more resistant to desensitization 
(Carpene et al., 1998). Epinephrine binds to the R-adrenergic receptors on 
adipocyte membranes and induces a conformational change in the receptor. This 
allows for the dissociation of the associated heterotrimeric G-proteins. The Ga
subunit exchanges guanosine monophosphate (GMP) for guanosine tri-phosphate 
(GTP), dissociates from the GpGY heterodimer, and translocates to interact with 
adenylyl cyclase. The Ga subunit may stimulate (GS) or inhibit (G;) adenylyl cyclase 
activity. Adenylyl cyclase, which is a membrane bound enzyme, catalyzes the 
conversion of adenosine tri-phosphate (ATP) to cyclic adenosine monophosphate 
(cAMP). Increased intracellular cAMP levels activate cAMP-dependent protein 
kinase A (PKA), which in turn phosphorylates and activates hormone-sensitive 
lipase. Activated lipase releases free fatty acids into the bloodstream. Glucagon, 
produced by the pancreas, stimulates hormone-sensitive lipase in the same manner 
through another G-coupled protein receptor, the glucagon receptor (Jiang & Zhang, 
2003). 
Catecholamine-mediated antagonism of insulin action further intensifies 
adipose catabolism by lowering plasma insulin levels and by reducing glucose 
uptake by adipose tissue. Through the activation of the abundant a2-adrenergic 
receptor population on B cells, catecholamines indirectly regulate lipogenesis in 
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adipose tissue (Filipponi et al., 1986). The a2-adrenergic receptor associates with 
the G; subunit, which lowers intracellular cAMP and inhibits voltage dependent 
calcium channels. This decreased intracellular calcium influx disrupts the exocytosis 
of insulin from pancreatic B cells (Hsu et al., 1991). In adipose, catecholamines 
diminish the effects of insulin directly. Activation of ~i3-adrenergic receptors 
stimulates the cAMP-PKA pathway. This attenuates insulin-induced glucose uptake 
via the inhibition of insulin-sensitive glucose transporter (GLUT4) translocation to the 
cellular membrane (Carpene et al., 1993; Yen et al., 1998). Additionally, GLUT4 
transcription is selectively repressed by increased CAMP concentrations in cultured 
adipocytes (Kaestner et al., 1991), which provides along-term interruption of 
glucose uptake and slows adipose hypertrophy. 
Catecholamine Regulation of Muscle Protein Turnover 
In order for skeletal muscle to hypertrophy, myofibrils, which are the highly 
ordered protein networks responsible far muscle contraction and shape, increase in 
size and number within the skeletal muscle cell, or myofiber. The rate of protein 
synthesis must exceed protein degradation for hypertrophy to occur, as newly 
synthesized myofibrils add to existing myofibrils to increase cell size. These 
processes are highly regulated by nutritional, hormonal, and mechanical stimuli. 
Even though catecholamines are predominantly associated with adipose catabolism, 
both epinephrine and norepinephrine modify the anabolic processes associated with 
muscle hypertrophy under certain physiological conditions. 
The inhibition of catecholamine action by adrenal ablation increases 
proteolysis by 20% in rat skeletal muscle (Navegantes et al., 2002). Epinephrine 
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activates the cAMP-PKA pathway via the ~i2-adrenergic receptor and selectively 
inhibits calcium-dependent proteolysis in rat skeletal muscle (Navegantes et al., 
2000). Calcium-dependent proteolysis is mediated by the activation of the thiol 
proteases, µ-, m-, and p94 calpain, and the activity of a specific inhibitor, calpastatin 
(Goll et al., 1992}. The calpains cleave myofibrillar proteins that comprise the 
myofibril into smaller peptides. The selective inhibition of the calpains, therefore, 
supports muscle mass and has been implicated in muscle growth (Huang & 
Forsberg, 1998). Protein kinase A modifies calpastatin activity, which in turn alters 
protease activity (Gong et al., 1998), and may inhibit m-calpain activity (Shiraha et 
al., 2002; Smith et al., 2003). Both affects require phosphorylation of the target 
protein by PKA. Through this mechanism, epinephrine supports increased skeletal 
muscle size predominantly through the inactivation of proteoyytic processes in the 
rat . 
In cardiac muscle, the cAMP-PKA pathway regulates contractility in response 
to the activation of ~i-adrenergic receptors by epinephrine (Wallukat, 2002), but other 
catecholamine-initiated pathways appear to contribute to cardiac hypertrophy 
(Scheuer, 1999). Norepinephrine binds to a-adrenergic receptors, which stimulates 
the mitogen activated protein kinase (MAPK) pathway (Gillespie-Brown et al., 1995) 
and increases protein synthesis (Ponicke et al., 2001; Xiao et al., 2001; Xin et al., 
1997). In particular, the expression of hypertrophic markers, such as skeletal a-actin 
and oc- and ~3-myosin heavy chain, increases in cardiomyocytes treated with 
norepinephrine (Bishopric & Kedes, 1991; Bishopric et al., 1987; Long et al., 1991). 
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The a-adrenergic activation of the MAPK pathway requires association of a 
Gq-dependent pathway (Naor et al., 2000). The guanine exchange protein Gq
selectively activates phospholipase C, which cleaves membrane phospholipids into 
the second messengers diacylglycerol (DAG), and inositol 1,4,5-triphosphate (IP3). 
Inositol 1,4,5-triphosphate increases intracellular calcium release from the 
endoplasmic reticulum and free calcium stimulates calmodulin kinase II (CaMK II) 
activity, which activates the MAPK pathway through the activation of Ras protein. 
The R-adrenergic receptors may also activate MAPK, although this appears to 
require both GS activation of the cAMP-PKA pathway and G; activation of Src/Ras 
signaling pathways (Yamazaki & Yazaki, 2000). The ability of catecholamines to 
induce protein synthesis in skeletal muscle may follow similar mechanisms, but 
considerably more work has been done in cardiac muscle, as catecholamines have 
been implicated in the progression of pressure overload myocardial hypertrophy 
(Rapacciuolo et al., 2001). 
~Adrenergic Receptor Desensitization 
The prolonged exposure to catecholamines may be detrimental to the target 
cell. Receptor desensitization is one mechanism by which the body protects itself 
against cellular damage. The R~- and ~i2- adrenergic receptor subtypes, in a ligand 
bound state, are susceptible to phosphorylation by both PKA and R-adrenergic 
receptor kinase (~3ARK) family members (Strosberg, 1995). Upon dissociation of the 
heterotrimeric G-proteins, the GRGY subunits recruit (SARK to the ligand bound 
receptor while prolonged accumulation of cAMP mediates PKA localization to the 
11 
receptor. The ensuing phosphorylation event stimulates endocyosis of the ~3-
adrenergic receptor through a clathrin-coated vesicle, a process referred to as 
homologous receptor desensitization (Luttrell & Lefkowitz, 2002). Receptor 
endocytosis leads to either recycling to the membrane or, more commonly, 
lysosomal degradation of the ligand-bound receptor. Interestingly, the ~i3-adrenergic 
receptor is resistant to phosphorylation by PKA and MARK family members, as this 
subtype lacks targeted phosphorylation domains (Strosberg, 1995). While this is not 
the only mechanism known to attenuate ~3-adrenergic responsiveness in the target 
cell, it is the most common and provides the most direct feedback inhibition. 
Synthetic Adrenergic Receptor Agonists 
As the study of epinephrine and norepinephrine action through their 
respective receptors evolved, so did the desire to design synthetic structural 
analogues capable of activating specific adrenergic receptor subtypes for both 
research and clinical applications. Today, adrenergic receptor agonists and 
antagonists are effective clinical treatments for shock, hypotension, hypertension, 
cardiac arrhythmias, congestive heart failure, nasal decongestion, asthma, weight 
reduction, narcolepsy, and attention-deficit hyperactivity disorder (ADHD) (Hoffman, 
2001) . 
~Adrenergic Receptor Agonists in Livestock Production 
Early work with epinephrine indicated that it increases adipose catabolism 
and that this effect mediated by activation of the ~3-adrenergic receptors. In 
livestock, such a response would be beneficial to the production of lean meat 
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products. Beginning in 1984, several studies demonstrated that (3-adrenergic 
agonists were effective modifiers of body composition in livestock species. One of 
the first reports demonstrated that clenbuterol not only decreased fat deposition, but 
also surprisingly increased total body protein content in broiler chickens (Dalrymple 
et al., 1984). Similar reports soon followed. In the pig, clenbuterol (Jones et al., 
1985), cimaterol (Mersmann et al., 1987), salbutamol (Warriss et al., 1990b), and 
ractopamine (Watkins et al., 1990) all decreased carcass fat and increased muscle 
volume. Sheep (Kim et al., 1987), steers (Moloney et al., 1990), mice (Rothwell & 
Stock, 1985), rats (Reeds et al., 1988), and quail (Merkley &Garwood, 1989) all 
respond positively to various ~i-adrenergic agonists, as evidenced by increased lean 
body composition. The unexpected improvement in carcass protein content 
stimulated further research into the efficacy and potential economic benefit of these 
compounds to enhance efficient meat production. 
Ractopamine 
Although efficacy and toxicological studies have since identified a number of 
effective ~i-adrenergic agonists, ractopamine is currently the only commercially 
available agonist approved by the United States Food and Drug Administration 
(FDA) for use in livestock. Producers may feed this orally active ~3-adrenergic 
agonist to swine from 68 to 109 kilograms of body weight with no pre-slaughter 
withdrawal time (FDA, 2002). Even though other ~3-adrenergic agonists may 
become legally available to producers in the future, the remainder of this review will 
focus on the biological response to ractopamine in swine. 
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Ractopamine: Growth and Body Composition 
Watkins et al. (1990) reported that ractopamine improved the rate of average 
daily gain and feed utilization (feed:gain) in the pig. Carcass composition also 
improved significantly. Carcass dressing percentage, longissimus muscle area, 
dissected carcass lean, and estimated fat-free muscle percentage increased in a 
dose dependent manner, while the undesirable carcass traits of carcass fat depth, 
average backfat, and dissected fat decreased after feeding ractopamine. Others 
have reported similar findings (Moody et al., 2000; Stites et al., 1991; Wray-Cahen et 
al., 1998). These responses are consistent regardless of sex (Dunshea et al., 
1993b; Uttaro et al., 1993; Williams et al., 1994), genotype (Bark et al., 1992; Gu et 
al., 1991; Yen et al., 1990; Yen et al., 1991), and final slaughter weight(Crome et 
al., 1996} of the ractopamine treated pigs. 
Ractopamine: Affects on Meat Quality 
In order for ~i-adrenergic agonists to truly make an impact in livestock 
production systems, they must have no adverse effects on product quality. Reports 
addressing the effects of ractopamine on pork quality are often contradictory and 
inconsistent. Some studies have found that ractopamine does not adversely affect 
quality traits (Crome et al., 1996; Watkins et al., 1990) while others suggest that pork 
from treated pigs is paler in color, tougher, and firmer (Uttaro et al., 1993), qualities 
that are not appealing to consumers. Marbling and water holding capacity are 
unaffected in most trials (Crome et al., 1996; Uttaro et al., 1993). However, 
salbutamol adversely affects pork color (Warriss et al., 1990a; Warriss et al., 1990b) 
and other ~i-adernergic agonists appear to adversely affect meat tenderness in 
14 
ruminant species (Bardsley et al., 1992; Parr et al., 1992; Pringle et al., 1994; Speck 
et al., 1993). It is unclear why responses differ across species or why certain ~i-
adrenergic agonists are more detrimental to product quality than others are. 
Differences in dose, treatment duration, and genetic backgrounds of the tested 
animals, as well as sampling techniques, could account for the discrepancies 
between these studies. Nonetheless, the response to ~i-adrenergic agonists 
deserves more consideration by meat scientists in order to ensure that the 
incorporation of these compounds into modern production systems is not detrimental 
to product quality. 
Ractopamine: Potential Nutritional Constraints 
While ractopamine can be effectively used to manipulate growth and 
composition, there may be room for further adjustment to design truly cost-effective 
nutrition programs that maximize biological response. An interaction appears to 
exist between ractopamine treatment and nutrient density of the diet. Increased 
dietary crude protein (Adeola et al., 1990; Dunshea et al., 1993a; Xiao et al., 1999), 
energy density {Williams et al., 1994), or both {Mitchell et al., 1991) may be required 
to elicit a maximal response. This is apparently due to the fact that animals treated 
with ~3-adrenergic agonists tend to consume less feed per unit of body mass and 
have enhanced muscle growth, which may require increased crude protein input 
and/or optimized amino acid distribution in the diet (Reeds & Mersmann, 1991). The 
concept of limited performance through the restriction of dietary protein is particularly 
evident in genotypes with a high capacity for lean gain (Bark et al., 1992). 
Additionally, trends observed in one study indicate that the amino acid composition 
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of longissimus dorsi muscle may change in response to ractopamine (Xiao et al., 
1999). Nutritional studies conducted more recently in the pig have been designed to 
optimize dietary energy density and protein content in order to maximize the 
response to ractopamine in modern swine genotypes (Trapp et al., 2002; Weber et 
al., 2002; Webster et al., 2002). 
Ractopamine as a Repartitioning Agent 
Hammond (1952) proposed that the manipulation of physiological parameters 
that regulate nutrient utilization in livestock species is the most efficacious means to 
maximize production and achieve a desired phenotype. In this model, evolutionary 
mechanisms direct the utilization of absorbed nutrients preferentially along a tissue 
hierarchy that supports the maturation of vital tissues first (brain, central nervous 
system, and gastrointestinal tract), followed by structural tissue (the skeleton and 
skeletal muscle), and finally reserve deposits (fat). The observed changes in body 
composition and growth rate, as well as the divergence of tissue deposition from 
more established patterns of development, suggest that ractopamine alters the 
coordinated regulation of metabolism to support and enhance lean growth. 
However, sufficient detail, particularly at the cellular level, as to how this is 
accomplished remains largely elusive (Eisemann, 1994). 
~l3-Adrenergic Receptors in Porcine Tissue 
The coding sequences for all three ~i-adrenergic receptor subtypes expressed 
in pig tissues share a high level of homology with other mammalian species (Cao et 
al., 1998; Liang et al., 1997; Smith et al., 2001). While heterogeneously expressed, 
the X31-adrenergic receptor is the predominant subtype in most porcine tissues 
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(McNeel &Mersmann, 1999). Quantification of mRNA abundance by reverse 
transcription revealed unequal transcript distribution in porcine heart (72% ~i1: 28% 
~i2: 0.25% ~i3), skeletal muscle (60%: 39%: 0.7%), subcutaneous adipose (73%: 
20%: 7%), lung (67%: 33%: 0.2%), and liver (45%: 55%: 0.0%). These values are in 
agreement with competitive displacement assays (Liang &Mills, 2002). Based on 
these findings and Limited kinetic studies (Spurlock et al., 1993), ractopamine was 
designated as a specific agonist for the ~i1-adrenergic receptor subtype (Moody et 
al., 2000). In contrast, other ~i-adrenergic agonists capable of modifying body 
composition, such as clenbuterol, are specific for the X32-adrenergic receptor subtype 
(Mersmann, 1998). 
Effect of Ractopamine on Adipose in the Pig 
Peterla and Scanes (1990) treated excised porcine adipose tissue from 
market weight pigs with ractopamine in vitro. By monitoring glycerol and free fatty 
acid release, as well as the incorporation of carbon-14 labeled glucose into fatty 
acids, they determined that ractopamine stimulated lipolysis and slowed the rate 
lipogenesis similar to epinephrine. When reduced to the cellular level, ractopamine 
increased CAMP accumulation (Mills et al., 2003) and lipolysis (Liu et al., 1989; Mills 
et al., 2003; Weber et al., 1992), antagonized insulin action (Dubrovin et al., 1990; 
Liu &Mills, 1990; Mills et al., 1990), and decreased fatty acid synthase activity 
(Weber et al., 1992) in adipocytes. These observations are consistent with 
increased lipid catabolism via activation of ~3-adrenergic receptors. Recently, Mills et 
al. (2003) demonstrated that ractopamine was equally efficacious at activating 
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lipolysis and cAMP accumulation via both cloned ~i1- and ~i2-adrenergic receptors, 
which the investigators over expressed in porcine adipocytes. However, 
investigations into the effects of ractopamine in vivo provide sufficient evidence that 
these effects are transient and probably do not contribute to long-term fat reduction 
and manipulation of body composition. 
In unpublished data discussed by Liu et al. (1994a), the inclusion of 
ractopamine for one feeding interval increased plasma concentration of non- 
esterified fatty acids within one hour in the pig, but this lipolytic response declined 
with subsequent feedings and plasma concentrations returned to basal levels within 
five days. Furthermore, acetyl-CoA carboxylase expression and activity did not 
change in fat depots isolated from ractopamine fed pigs, which signifies the lack of 
commitment to sustainable decreases in enzymatic activity and subsequent rates of 
lipogenesis (Liu et al., 1994a). Interestingly, this same group reported that acetyl- 
CoA carboxylase expression and activity decreased in porcine adipose after 
treatment with recombinant porcine somatotropin, or growth hormone, (Liu et al., 
1994b), which stimulates the somatotropic axis to modify body composition in the 
pig • 
Using an approach that combined in vivo treatment with in vitro analysis, Mills 
et al. (1990) removed subcutaneous fat from ractopamine fed pigs and measured 
lipolysis, fatty acid sythesis, malic enzyme activity, and insulin action in adipose and 
isolated adipocytes. When adipocytes where isolated from ractopamine fed pigs, in 
vivo lipolysis could only be stimulated to 40% of control levels by additional 
ractopamine treatment. Further, insulin binding in adipose tissue samples was 
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unaffected by feeding ractopamine. These results suggest that the ractopamine-
responsiveness is diminished over the duration of treatment in adipose tissue in an 
insulin-independent manner. 
As ~3-adrenergic receptor number decreases in porcine tissue over the course 
of treatment (Sainz et al., 1993; Spurlock et al., 1994), ractopamine most likely 
provokes homologous receptor desensitization. Disagreement with regard to the 
action of ractopamine on adipose metabolism may be a result of this phenomenon. 
It is likely that in vitro models fail to recapitulate along-term response to ractopamine 
but provide a true indication of the early metabolic response (increased lipolysis, 
cAMP accumulation, and antagonized insulin action). The lack of committed gene 
expression and up-regulation of lipolytic enzymes indicates that prolonged exposure 
to ractopamine may establish a feedback inhibition, which attenuates ~i-adrenergic 
receptor signaling and subsequent changes in metabolism in vivo. The long-term 
regulation of fat deposition may not be a direct effect of ractopamine on fat depots 
but rather an indirect effect on nutrient sequestration by other more metabolically 
active tissues. 
Effect of Ractopamine on Skeletal Muscle in the Pig 
~i-Adrenergic agonists increase muscle mass in vivo (Beermann, 2002; Kim & 
Sainz, 1992). Increased cell number, increased fiber length, or increased fiber area 
are three mechanisms known to increase skeletal muscle mass (Pearson, 1990). As 
increased cell number, or hyperplasia, is restricted to prenatal and early postnatal 
development in the pig, ractopamine increases muscle mass by regulating the latter 
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two mechanisms. However, sufficient detail as to how this is accomplished has 
remained elusive. 
Ractopamine and Protein Accretion 
In order for muscle hypertrophy to occure, the myofiber increases in size by 
the addition of new sarcomeres (length) to the existing myofibrils and/or by the 
addition of new myofibrils (diameter} to the myofiber. This requires increased 
protein expression in the myofiber. In the pig, ractopamine positively augments net 
protein accretion, as fractional protein synthesis increases (Adeola et al., 1992; 
Adeola et al., 1990; Bergen et al., 1989) with no apparent change in proteolysis 
(Bergen et al., 1989; Sainz et al., 1993). Adeola et al. (1992) further demonstrated 
that ractopamine increased the fractional synthesis rates for myofibrillar proteins 
relative to sarcoplasmic protein synthesis in the longissimus dorsi and biceps 
femoris muscles. Additionally, ractopamine increased myofibrillar protein synthesis 
in both rat (Anderson et al., 1990) and C2C12 mouse myotubes (Shappell et al., 
2000) in cell culture. 
Skeletal a-actin is the predominant actin isoform present in the myofibrillar 
fraction of mature striated muscle (Bandman, 1992) and mRNA abundance 
increases in skeletal muscle during rapid postnatal growth in pigs (Chang et al., 
1994). Therefore, increased steady state mRNA levels of skeletal a-actin indicate a 
pre-translational commitment to hypertrophy. Ractopamine stimulates increased 
skeletal a-actin mRNA abundance in pigs (Grant et al., 1993; Helferich et al., 1990; 
Liu et al., 1994a), as well as in steers (Smith et al., 1989), without a general 
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enhancement of muscle mRNA abundance. This is also true for rat skeletal muscle 
after cimaterol treatment (Kim et al., 1997). 
Skeletal muscle is comprised of a heterogeneous population of individual 
myofibers. Each myofiber has distinct contractile and metabolic properties (Aberle 
et al., 2001) as well as myosin heavy chain (MHC) isoform expression patterns 
within the sarcomeres (Gerrard &Grant, 2003). Slow contracting type I and IIA 
fibers express the MHC isoforms I and IIA, respectively, and utilize oxidative 
metabolic pathways, Fast contracting type IIB fibers express predominantly MHC 
IIB and are glycolytic. An intermediate fiber type, which express MHC IIX, are 
glycolytic-oxidative (type IIX(D)). 
Evidence suggests that R-adrenergic agonists also regulate the expression of 
the myosin heavy chain isoforms. In pigs fed ractopamine, the relative proportion of 
type I, type IIA, and type IIX(D) fibers decreases while the proportion of type IIB 
fibers increases in several muscles (Depreux et al., 2002). Though neither study 
differentiated between the MHC isoforms, ractopamine stimulated the in vitro rate of 
MHC synthesis in C2C12 (Shappell et al., 2000) and rat myotubes (Anderson et al., 
1990). Myosin heavy chain mRNA abundance was also elevated in cimaterol 
treated chicken myotubes (Young et al., 1990). 
Satellite Cell Proliferation 
The Cheek hypothesis suggests that each myonuclei within a multinucleated 
myofiber controls a finite cytoplasmic volume (Cheek et al., 1971). Therefore, as the 
myofiber hypertrophies, DNA content of the cell must increase to support gene 
transcription and subsequent protein synthesis. Mitotically competent satellite cells 
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proliferate, differentiate, and fuse to the existing myofiber to match this demand 
(Allen &Rankin, 1990). 
Ractopamine failed to significantly increase satellite cell proliferation in 
porcine cultures as the number of myotube nuclei (Grant et al., 1990b) and DNA 
content (Cook et al., 1995} were unchanged after treatment. Further, one in vivo 
study noted that DNA content in porcine longissimus dorsi muscle did not change 
after administration of ractopamine (Grant et al., 1993). While ractopamine's 
influence on satellite cell proliferation in vivo remains unexplored, the combined 
results of these studies indicate that it is unlikely that ractopamine directly regulates 
satellite cell proliferation in the pig. Even as it is likely that increased protein 
synthetic demand in porcine muscle would require later incorporation of satellite 
cells into the growing myofiber, the initial stimulation of satellite cell proliferation 
does not appear to be a prerequisite for ractopamine-induced hypertrophy. 
However, in both chicken (Grant et al., 1990a) and C2C12 mouse (Shappell et al., 
2000} myoblast cultures, ractopamine increased myotube nuclei and culture DNA 
content, respectively. The apparent species difference has not been resolved, but 
variations in the expression of ~i-adrenergic receptor subtypes exist across species 
(Izevbigie &Bergen, 1996b; Young et al., 2000) and may hinder the extrapolation of 
these findings to the pig. 
Signal Transduction 
In immature skeletal muscle, cAMP accumulates in differentiated myotubes 
after ractopamine treatment (Cook et al., 1995; Izevbigie &Bergen, 1996a; Izevbigie 
& Bergen, 1996b; Shappell et al., 2000}. Other ~3-adrenergic agonists also increase 
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cAMP levels in rat skeletal muscle (Kim et al., 1997). A causal association between 
this increase in second messenger level and increased protein synthesis in 
response to ractopamine remains speculative (Beermann, 2002; Mersmann, 1998; 
Mills, 2002; Moody et al., 2000). As porcine ~i-adrenergic receptors appear to be 
susceptible to homologous receptor desensitization in response to ractopamine 
treatment (Sainz et al., 1993; Spurlock et al., 1994), cAMP accumulation in porcine 
skeletal muscle is probably transient and rapidly attenuated. However, the 
increased rates of protein synthesis (Adeola et al., 1992; Adeola et al., 1990; Bergen 
et al., 1989) and expression of myofibrillar specific proteins (Depreux et al., 2002; 
Grant et al., 1993; Helferich et al., 1990) persists over an extended time course of 
treatment. This implies that other molecular mechanisms may be responsible for, or 
involved in, ractopamine-induced skeletal muscle hypertrophy. 
Aims of This Study 
As outlined above, prolonged ~i-adrenergic stimulation by administration of 
synthetic ~3-adrenergic receptor agonists induces favorable changes in body 
composition and improves growth efficiency in the pig. These effects appear to be 
the culmination of changes of many biological processes, which includes enzymatic 
activity, substrate utilization, and gene expression. Sufficient detail as to how this is 
accomplished has remained elusive, even though this question has been a focus of 
animal scientists for the last quarter of a century. 
Modified gene expression accompanies phenotypic changes when skeletal 
muscle undergoes both hypertrophy (Carson, 1997; Goldspink, 2002) and atrophy 
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(Bey et al., 2003; Wittwer et al., 2002). While not a requirement, sustained 
increases in transcription of proteins involved in ion transport, biochemical pathways, 
cellular integrity, and signal transduction pathways tend to indicate cellular 
adaptations to stimuli that promote hypertrophy. For those interested in the 
mechanisms that control gene regulation, the initial identification of genes regulated 
by trophic or mechanical factors, for instance, provides a framework from which to 
develop innovative hypothesis-driven research, as this approach often incriminates 
novel signal transduction pathways and molecular events that are not fully 
appreciated. 
The aims of this study were to 1) determine the mechanism by which 
ractopamine regulates the expression of the porcine skeletal a-actin gene and 2) to 
identify genes that are potentially regulated by ractopamine in porcine skeletal 
muscle. While ambitious, this study promises to provide a foundation for the further 
identification of ractopamine-induced regulatory mechanisms that promote increased 
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CHAPTER 2. TRANSCRIPTIONAL RESPONSIVENESS OF 
PORCINE SKELETAL a-ACTIN TO RACTOPAMINE IN 
PORCINE MYOTUBES 
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Abstract 
Increased expression of skeletal a-actin (Sk-a-Act) parallels increased 
myofibrillar protein expression and muscle hypertrophy in pigs fed ractopamine. 
Porcine satellite cell~cultures were established to determine if ractopamine directly 
regulates the expression of the Sk-a-Act gene via known cis-acting DNA elements. 
Differentiated myotubes were treated with ractopamine (10 µlV/j in serum-free media 
and Sk-a-Act mRNA was quantified by real-time reverse transcriptase polymerase 
chain reaction (RT-PCR). After 72 h of treatment, Sk-a-Act mRNA abundance 
increased six-fold relative to untreated control cultures. Total protein concentrations 
in ractopamine treated cultures tended to be higher after 72 h (P = 0.07). Luciferase 
expression plasmids containing 5' regulatory regions of the porcine Sk-a-Act gene 
were transiently transfected into porcine satellite cell cultures and cells were 
stimulated to differentiate into myotubes. Ractopamine (10 µlVn was added to 
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serum-free media and cell lysates were assayed for luciferase activity. Ractopamine 
failed to increase transcriptional activity of the cloned full-length Sk-a-Act promoter 
(DNA sequences -1929 to +243 by relative to the transcriptional start site), but basal 
activity increased over a 72-h time course (P < 0.001). Further, luciferase 
expression assays with truncated promoter constructs failed to identify a 
ractopamine-responsive DNA element in the cloned Sk-a-Act promoter. Our results 
indicate that the known cis-acting DNA elements previously described 5' of the 
porcine skeletal a-actin encoding gene do not confer transcriptional responsiveness 
to ractopamine in porcine skeletal muscle despite observed increases in Sk-a-Act 
mRNA abundance in vitro after ractopamine stimulation. 
Keywords: ractopamine, pig, skeletal a-actin, expression, transcription 
Introduction 
Ractopamine and other ~3-adrenergic agonists stimulate muscle hypertrophy 
in vivo (Beermann, 2002; Kim & Sainz, 1992). In porcine skeletal muscle, 
ractopamine positively augments net protein accretion, as fractional protein 
synthesis increases with no apparent change in proteolysis (Adeola et al., 1992; 
Adeola et al., 1990; Bergen et al., 1989; Sainz et al., 1993). Specifically, 
ractopamine increases the fractional synthetic rate of myofibrillar proteins in the 
longissimus dorsi and biceps femoris muscles (Adeola et al., 1992). In vitro, 
ractopamine increases myofibrillar protein synthesis in both rat (Anderson et al., 
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1990) and C2C12 mouse myotubes (Shappell et al., 2000). These results, and 
evidence that ractopamine selectively activates the ~3-adrenergic receptor population 
on skeletal muscle membranes (Spurlock et al., 1994), indicate that ractopamine has 
a direct effect on anabolic processes that ultimately lead to skeletal muscle 
hypertrophy. 
Skeletal a-actin (Sk-a-Act) is the predominant actin isoform present in the 
myofibrillar fraction of mature striated muscle (Bandman, 1992) and Sk-a-Act 
expression increases in skeletal muscle during rapid postnatal growth in pigs (Chang 
et al., 1994). Skeletal a-actin mRNA abundance in pigs (Grant et al., 1993; Helferich 
et al., 1990; Liu et al., 1994) and steers (Smith et al., 1989) increases in response to 
ractopamine without a general increase in total muscle mRNA. These results 
indicate that ractopamine may stimulate skeletal muscle hypertrophy and protein 
accretion through the expressional regulation of muscle specific genes. However, 
the molecular mechanisms by which ractopamine regulates SK-a-Act expression 
pre-translationally have not been identified. We hypothesized that the increase in 
Sk-a-Act mRNA was regulated at the level of transcription. 
Materials and methods 
Primary Cell Culture 
Porcine satellite cells were isolated from three-week-old gilts as described 
(Blanton et al., 2000; Doumit &Merkel, 1992). All .animal handling procedures were 
approved by the Iowa State University Committee on Animal Care. Hindlimb muscles 
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(180 to 200 g) were surgically removed and mechanically dissociated in a sterilized 
meat grinder. Satellite cells were further isolated by digestion with bacterial protease 
(Type XIV at 1.2 mg/mL in phosphate buffered saline (PBS); Sigma Chemical Co., St. 
Louis, MO) for 40 min at 37°C and differential centrifugation. Satellite cells were then 
suspended in a growth media (GM) that contained minimum essential media (MEM; 
Fisher Scientific, Pittsburgh, PA) supplemented with 10% fetal bovine calf serum 
(FBS; Atlanta Biologicals, Norcross, GA), L-glutamine (250 µg/mL; Sigma), penicillin 
(100 U/mL; Sigma), streptomycin (100 µg/mL; Sigma), fungizone (0.12 µg/mL; 
Invitrogen Corporation, Carlsbad, CA), and gentamicin (10µg/mL; Invitrogen). Cells 
were plated at an initial density of 125 mg/cm2 on 35-mm cell culture dishes coated 
with Matrigel (Becton Dickinson, Bedford, MA) and cultured in a 5% CO2 humidified 
incubator set to 37°C. After an attachment period of 24 to 36 h, cultures were rinsed in 
MEM to remove residual debris and GM was replenished. every 48 h thereafter unless 
otherwise noted. 
Satellite Differentiation and Addition of Treatment Media 
At 85 to 90% confluence, satellite cells were stimulated to differentiate into 
myotubes for 36 h by the addition of differentiation media (2% DM), which contained 
MEM, 2% horse serum (Fisher), L-glutamine (250 µg/mL), penicillin (100 U/mL}, 
streptomycin (100 µg/mL), and insulin (10-7 M; Sigma). Cells were rinsed with MEM 
before addition of treatment media. Treatment media consisted of Ractopamine (10 
µMin H2O; Lilly Research Labs, Greenfield, IN) or volume equivalent vehicle control 
(H20) in serum-free differentiation media (SFDM) modified from that previously 
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described for porcine satellite cells (Doumit et al., 1996). Serum-free media 
contained MEM and MCDB-110 (Sigma) in a 4:1 ratio, bovine transferrin (100 
µg/mL; Sigma), bovine serum albumin (0.5 mg/mL BSA; Fisher), insulin (10µM), 
linoleic acid (0.5 µg/mL; Sigma), and dexamethasone (25 µM; Calbiochem, San 
Diego, CA). Treatment media was replenished every 24 h. 
Total RNA Isolation from Porcine Cultures 
After 72 h in treatment media, total RNA was harvested with TRlzol reagent 
(Invitrogen) as described by the manufacturer's protocol. Three representative 
cultures were collected, pooled, and processed. Total RNA was suspended in 15µL 
of RNAse-free water and incubated with amplification grade Rnase-free DNase I (1 
U; Invitrogen) for 15 min at room temperature to remove residual genomic DNA 
contamination. DNase I was inactivated by the addition of 25 mM EDTA and 
incubation at 65°C for 10 min. 
First-strand cDNA synthesis 
First-strand cDNA was synthesized in a 20 µL reaction which contained 1.0 
µg of total RNA, 10 mM dNTP mix (10 mM each dATP, dCTP, dGTP, and dTTP), 
100 mM 1,4-Dithio-DL-threitol (DTT), 15 U ANTI-Rnase (Ambion, Inc., Austin, TX), 
50 ng oligo (dT) 10_20 primer (Invitrogen), 4µL of 5X reaction buffer, Superscript II 
Rnase- H reverse transcriptase (200 U; Invitrogen), and diethyl pyro-carbonate 
(DEPC) treated H2O to volume. The reaction was performed at 42°C for 50 min. 
Synthesized cDNA was diluted to the equivalent of 25 ng total RNA per 1µ,L of 
cDNA and stored at —20°C. 
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Quantitative Detection of mRNA Species 
Quantitative PCR analysis was conducted with a Smart Cycler (Cepheid, 
Sunnyvale, CA) and SYBR Green I dye (Applied Biosystems, Foster City, CA) in 
order to determine the relative expression levels of Sk-a-Act and glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) in primary porcine myotubes. The 
concentration of double-stranded DNA after each cycle of amplification was 
monitored by SYBR Green I fluorescence. Each PCR reaction contained 300 nM 
(each) of gene specific primers, 10µL of 2.5X SYBR Green Master Mix, 0.5 µL of 
cDNA, and sterile water to a final volume of 25 µL. After denaturation (95°C for 10 
min), forty cycles of PCR were performed (95°C for 15 s, primer specific annealing 
temperature for 30 s, 72°C for 30 s, and fluorescence acquisition at a product-
specific temperature for 10 s). Fluorescence data was captured by Smart Cycler 
optics after the last step of each cycle to minimize the capture of non-specific (primer 
dimer} product data. For Sk-a-Act, a 193-base pair (bp) amplicon was produced 
from forward (5'-GAG GCG AAC TAC TCC GTG TG-3') and reverse (5'-GTC AGC 
CAC TGC ACT TGA GC-3') primer pairs designed to amplify the seventh exon and 
3'UTR of the known encoding gene (4263-4455 by of GenBank accession number 
U 16368). A second set of primers, forward (5'-TCC CTG CTT CTA CTG GTG CT- 
3') and reverse (5'-CAC AAC CTG GTG CTC AGT GT-3'), was designed to amplify 
a 227-bp fragment of G3PDH (955-1182 by of AF017079}. Annealing temperature 
for Sk-a-Act was 55°C and fluorescence captured at 82.5°C, while 58°C and 84°C 
were used for G3PDH. Product specificity was confirmed by melting curve analysis 
(55°C to 95°C ramp, 0.1 °C per s), the identification of expected product Tm (85.7°C 
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for Sk-a-Act; 86.6°C for G3PDH), and by agarose gel electrophoresis of each 
amplicon (Figure 1). For each gene, mRNA transcript abundance was quantified by 
the inclusion of linear internal standards generated by PCR subcloning. Each 
sample was analyzed in duplicate within the same Smart Cycler run. Data was 
accepted when the standard curve had an R2 >_ 0.98 and individual samples had a 
CV of less than 5%. 
Cloning of Internal PCR Standards 
Each target amplicon was subcloned into pGEM-T Easy vector (Promega) as 
described by the manufacturer's. Amplicons were generated from 1µL of porcine 
muscle cDNA from mature skeletal muscle RNA in a 10µL reaction, which contained 
10X reaction buffer, magnesium chloride (2.5 mM), dNTPs (20 nM), gene specific 
primers (5 mM each), and Taq DNA polymerase (0.5 U; Promega). After forty cycles 
of amplification (95°C for 5 min followed by 40 cycles of 95°C for 15 s, 60°C for 15 s, 
72°C for 15 s) on a standard thermal cycler, PCR products were ligated into pGEM 
vector overnight at 4°C. Plasmid DNA was purified (Plasmid Midi Kit, Qiagen, 
Valencia, CA) and eluted in H2O (pH 8.0). Insert identity was confirmed by 
sequence analysis on an ABI 377 sequencer (Applied Biosystems, Inc.) at the Iowa 
State University DNA Sequencing Facility with T7 (5'-AAT ACG ACT CAC TAT AG- 
3') primer. Sequences were compared with entries in GenBank by BLAST analysis 
to assure homology to known porcine sequences. Plasmid DNA was linearized by 
digestion with Apal , quantified (A2so), and serially diluted to form a linear internal 
standard for inclusion in PCR reactions. Copy number for linear plasmid standards 
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was estimated with the following equation: 6 x 1023 (copies/mol) x plasmid 
concentration (g/µL) x MW~' (g/mol). 
Luciferase Expression Plasmid Construction 
The generation of porcine genomic clones and characterization of the porcine 
Sk-a-Act promoter has been described (Reecy et al., 1998; Reecy et al., 1996). The 
chloramphenicol acetyltransferase (CAT) cDNA was removed from pPSKAFL-CAT 
(Reecy et al., 1996) by restriction endonuclease digestion with EcoRl and Safi and 
replaced with a firefly luciferase (LUC) cDNA from pGL3-basic (Promega, Madison, 
WI) to produce pPSKA-LUC. The newly formed luciferase encoding plasmid 
contained 1929 by of 5' flanking sequence, the first exon and 188 by of the first 
intron of the porcine Sk-a-Act gene (Figure 3). Promoter deletion constructs were 
generated by endonuclease digestion of pPSKA-Luc with BamM, Xbal, Smal, or 
Xhol and Hindlll similar to Reecy et al. (1998). Restriction fragments of expected 
length were gel purified (Qiagen QlAquick Gel Extraction Kit) and ligated, in frame, 
into pGL3-BASIC (Promega) 5' of the firefly luciferase reporter gene, to form 
pPSKA-Bam (nucleotides —550 to +243 of the porcine skeletal a-actin gene), 
pPSKA-Xba (-388 to +243), pPSKA-Sma (-142 to +243), and pPSKA-Xho (-84 to 
+243) (Figure 5). Plasmid DNA was purified (Qiagen Plasmid Midi Kit) and eluted in 
Tris-EDTA (pH 7.4) for storage at —20°C. 
Transient Transfections 
Transient transfection procedures were utilized to introduce luciferase 
constructs into primary cell cultures. Cells were transfected at 65 to 70% confluence 
with 2µg of total purified plasmid DNA with Fugene 6 (3 µL; Roche Applied Science, 
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Indianapolis, IN) as described in the manufacturer's protocol in antibiotic-free GM. 
In all experiments, a firefly luciferase reporter construct (1 µg) was co-transfected 
with a Rous Sarcoma Virus (RSV) promoter driven R-galactosidase reporter plasmid 
(1 µg), RSV-~iGAL (Reecy et al., 1997), to normalize for transfection efficiency. 
pGL3-Basic (Promega), which lacks a defined eukaryotic promoter, was transfected 
in parallel cultures to determine background luciferase expression. After 18 h of 
incubation, transfection media was removed and replaced with GM. Longer 
incubations in antibiotic-free media proved to be detrimental to primary cell survival 
(data not shown). Transfected cells were stimulated to differentiate and were 
treated with ractopamine (10 µll~ in serum-free media as described above. 
Reporter gene assays 
At times indicated, transfected cultures were rinsed twice with PBS and lysed 
by the addition of 220 µL of 1 X reporter lysis buffer (Promega) for 10 min at room 
temperature. Cultures were scraped and lysates were transferred to a 1.5 mL 
centrifuge tube. To ensure complete lysis, three cycles of rapid freeze (liquid N2) 
and thaw (37°C H2O bath) were performed on collected samples. Cell debris was 
removed by centrifugation at 20,000x g for 2 min at 25°C. Twenty microliters of 
lysate was mixed with 100 µL of luciferase substrate (20 mMTris, 4 mM MgSO4, 0.1 
mM EDTA, 30 mM DTT, 0.5 mM ATP, 0.25 mM Co-enzyme A, 0.5 mM D-luciferin 
pH 8.0) in a standard luminometer (TD-20/20; Turner Designs, Sunnyvale, CA) and 
chemiluminescence (expressed as relative light units, RLU) was measured for 15 s. 
R-Galactosidase activity was determined spectrophotometrically (420 nm) as 
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described (Rosenthal, 1987). Briefly, 50 µL of cellular lysate was incubated at 37°C 
for 6 to 18 h in 450 µL of Z buffer (2.70 µL/mL ~i-mercaptoethanol, 60 mM Na2HPO4, 
40 m M NaH2PO4, 10 m M KCI, 1 m M MgSO4 pH 7.0) supplemented with 100 µL of 2- 
Nitrophenyl ~i-D-galactopyranoside (ONPG; Sigma). To determine total culture 
protein levels, 10µL of cell lysate was loaded onto a 96-well microtitre plate and 
protein concentration was determined by the Bradford assay (Bio-Rad Corp, 
Hercules, CA) with a linear BSA standard as per the manufacturer's 
recommendations with a SPECTRAmax 340PC384 plate reader and Softmax Pro 4.0 
software (Molecular Devices, Sunny Vale, CA). Luciferase activity was normalized 
to ~3-galactosidase activity and expressed as RLU per ng of total protein. 
Statistical Analysis 
Data was analyzed by one- or two-way analysis of variance (ANOVA) with 
JMP software (Release 5.0, 2001; SAS Institute Inc., Cary, NC). For Luciferase 
expression assays, multiple experiments were pooled and a mixed model was 
applied to the composite data. The main effects of treatment, time (or construct), 
and respective interactions were determined, while the effects of experiment and 
experiment interactions were treated as random. When main effects were 
significant, least squared means (LSM) differences were determined by Tukey's 
HSD procedure, post hoc. Least squared means and the standard error of the mean 
are reported. Comparisons were significantly different at the level of P < 0.05. 
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Results and Discussion 
Quantitative PCR 
A two-step real-time quantitative RT-PCR approach was used to determine 
the relative mRNA abundance of Sk-a-Act in both ractopamine-stimulated and 
untreated porcine myotubes. This technique was optimized to minimize the 
amplification of non-specific amplicons (Figure 1). After 72 h in SFDM 
supplemented with ractopamine, SK-a-Act mRNA abundance increased more than 
six-fold relative to untreated control cultures (Table 1). Untreated myotube cultures 
contained approximately 12,800 copies of Sk-a-Act mRNA transcripts per picogram 
of total RNA, whereas ractopamine treated cultures contained 85,200 copies (Table 
1). 
Although the magnitude of response was greater in this study, our findings 
are in agreement with in vivo studies in which ractopamine increased SK-a-Act 
mRNA levels (Grant et al., 1993; Helferich et al., 1990; Liu et al., 1994). Similarly, 
skeletal a-actin mRNA abundance increased in vitro when ventricular myocytes 
were maintained in serum-free media supplemented with the ~i-adrenergic agonist 
isoproterenol (Bishopric et al., 1992b). In this study, the effect of ~i-adrenergic 
agonists on Sk-a-Act expression has been recapitulated in porcine myotubes 
maintained in SFDM. 
Average Protein Concentrations in Porcine Myotubes Treated with Ractopamine 
Protein synthetic rate has been documented to peak at 24 h in zinterol treated 
L8 muscle cells (McElligott et al., 1989), between 24 and 48 h in clenbuterol treated 
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L6 cultures (McMillan et al., 1992}, and after 24 h in ractopamine treated ELCS 
myotubes (Anderson et al., 1990). In this study, total protein concentrations were 
measured post hoc to determine if ractopamine increased protein synthesis during a 
time course that spanned 72 h in treatment media. 
The average protein content in harvested porcine myotubes was unchanged 
after treatment with ractopamine at 24 and 48 h, but tended to be higher after 72 h 
(P = 0.07; Figure 2). However, culture protein concentrations decrease in a time-
dependent manner. It should be noted that the serum-free treatment media 
described in this study contained the synthetic glucocorticoid dexamethasone at a 
final concentration of 2.5 µM. This level was previously reported to be optimal to 
increase ~3-adrenergic receptor populations in bovine myotubes as well as the 
apparent synthetic rate of myosin heavy chain in response to 1 µM isoproterenol 
(Bridge et al., 1998}. Our results are similar to those obtained by Desler et al. 
(1996), in which total cellular protein deceased adose-dependent manner in C2C12 
myotubes treated with dexamethasone in serum-free. Though we did not measure 
the apparent protein synthesis or degradation rates in this study, we believe that our 
results suggest that porcine myotubes may be more sensitive to this level of 
dexamethasone (2.5 µM) than bovine myotubes and, even in the presence of 
ractopamine, protein degradation may exceed synthetic rates, which explains the 
trends observed (Figure 2). However, dexamethasone does not adversely affect Sk- 
a-Act expression at the mRNA level (Koukouritaki et al., 1997, and this study), thus, 
these results do not directly affect the conclusions that may be drawn herein as our 
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objective was to measure transcriptional responsiveness of the Sk-a-Act promoter to 
ractopamine. 
Skeletal-a-Actin Promoter Responsiveness to Ractopamine 
In order to establish if ractopamine directly regulates the transcription of the 
porcine skeletal a-actin gene, luciferase reporter gene assays were performed. The 
porcine Sk-a-Act promoter, which contained ~1.9 kilobases (kb) of 5' DNA sequence 
(relative to the transcriptional start site), the first exon (55 bp), and 188 by of the first 
intron, was cloned 5' of luciferase cDNA to produce a 6.8 kb chimeric vector (Figure 
3). As previously reported (Reecy et al., 1998), this region of genomic DNA 
regulates the expression of porcine Sk-a-Act in a developmental and muscle specific 
manner. Although fibroblast contamination was never a significant problem in our 
primary cell culture model (data not shown), our luciferase promoter constructs were 
designed to retain muscle specific expression, which was conferred by an enhancer 
in the first intronic region (Reecy et al., 1998). Initial transfection experiments in 
untreated C2C12 myotubes, C2C12 myoblasts, and 10T ~h fibroblasts confirmed that 
all constructs used in this study behaved in a developmental and tissue specific 
manner (data not shown). 
In order to establish a time course for subsequent experiments, the full-length 
pPSKA-LUC plasmid was transfected as described into porcine myoblasts. Treated 
myotubes were harvested in 24-h increments and luciferase activity was evaluated. 
The cloned Sk-a-Act promoter did not respond to ractopamine after as many as 72 h 
in SFDM (Figure 4). However, basal promoter activity increased over time (P < 
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0.001). As depicted in Figure 5, experiments conducted with luciferase expression 
constructs driven by truncations of the full-length promoter further failed to respond 
to ractopamine after 72 h. From these experiments, we were unable to determine if 
a ractopamine responsive DNA element exists in the 5' flanking region (-1929 to 
+243 bp) of the porcine Sk-a-Act encoding gene. 
The constructs used in this study behaved similarly to previous reports that 
utilized the Sk-a-Act promoter; transcriptional activity decreased as the regions distal 
to the transcriptional start site were deleted (Bishopric & Kedes, 1991; Reecy et al., 
1998). Interestingly, Reecy et al. (1996) identified an enhancer region within the 
distal region of the porcine Sk-a-Act promoter (-1929 to —550 bp) that was required 
to confer a high level of transcriptional responsiveness in C2C12 myotubes. 
However, this region does not appear to have an enhancer-like function in porcine 
myotubes as the luciferase activity was not different when the full-length construct (- 
1929 to +243 bp) was compared to the both the pPSKA-Bam (-550 to +243) and 
pPSKA-Xba (-388 to +243) constructs regardless of ractopamine stimulation (data 
not shown). Nonetheless, transcriptional responsiveness was diminished, relative to 
the full-length promoter, in the absence of the serum-response elements (SRE) 
between —388 and —142 by (P < 0.01) and in absence of the SRE in the proximal 
DNA region (-142 by to —84; P < 0.001) of the Sk-a-Act promoter, which is 
consistent with previous reports (Bishopric & Kedes, 1991; Reecy et al., 1998). 
The expression, or in some species, re-expression, of Sk-a-Act is associated 
with cardiac hypertrophy and hypertension (Schwartz et al., 1992; Schwartz et al., 
1993) and, therefore, the adrenergic regulation of this gene has been most closely 
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examined in the context of cardiac, rather than skeletal, muscle hypertrophy. 
Interestingly, norepinephrine increased transcriptional activity of an enhancer-
containing human Sk-a-Act promoter (-2000 to +187 bp) by 2.4-fold in high-density 
cardiac myocytes via activation of the ~i-adrenergic receptors (Bishopric & Kedes, 
1991). In that study, a DNA region between —2000 and —36 by (relative to the 
transcriptional start site) conferred norepinephrine responsiveness. A DNA region 
located between -153 and -36 bp, which contains a binding site (-90 bp) for the 
transcription factor activator protein-1 (AP-1), was demonstrated to be necessary for 
isoproterenol-induced transactivation of the human Sk-a-Act promoter by a c-fos/c- 
jun heterodimer in cardiac myocytes (Bishopric et al., 1992a). This region is 
conserved between the human and porcine Sk-a-Act genes (Reecy et al., 1996). It 
is, therefore, unclear why both ractopamine and isoproterenol (data not shown) 
failed to induce the porcine Sk-a-Act promoter in a similar manner in porcine 
myotubes. Together with the increased pretranslational Sk-a-Act expression in our 
system, it is likely that DNA regulatory elements not included in the chimeric 
expression vectors described herein confer transcriptional responsiveness to 
ractopamine, if mRNA abundance is indeed a function of increased Sk-a-Act 
transcription. 
Alternatively, the increased Sk-a-Act mRNA abundance observed in response 
to ractopamine may result from increased mRNA stability. While this has not been 
previous postulated for ractopamine, other ~i-adrenergic agonists have been shown 
to positively and negatively regulate gene expression via post-transcriptional 
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mechanisms. Beta-actin mRNA abundance transiently increased independent of an 
increased nuclear transcription rate in the parotid glands of isoprenaline treated mice 
(Roberts et al., 1991). Conversely, a heteronuclear protein, hnRNP A1, selectively 
reduces the half-life of ~i1-adrenergic receptor mRNA transcripts in rat C6 glioma 
cells treated with isoproterenol (Kirigiti et al., 2001). In this case, hnRNP Al binds to 
the 3' untranslated region (UTR) of the ~i1-adrenergic receptor transcript to confer 
decreased mRNA stability. It is conceivable that ractopamine may selectively 
increase or decrease mRNA stability in a similar manner. With respect to Sk-a-Act 
and the apparent ractopamine-mediated increase in pre-translational expression, the 
3' UTR has not been studied. As Sk-a-Act mRNA abundance increases 
independent of a global increase in mRNA transcription (Grant et al., 1993; Helferich 
et al., 1990), further investigation into the post-transcriptional control of gene 
expression appears to be warranted. 
Implications 
While other studies have provided evidence that ractopamine regulates the 
expression of Sk-a-Act and possibly myosin heavy chain isoforms (Depreux et al., 
2002; Shappell et al., 2000), the molecular mechanisms underlying these effects are 
poorly understood. This is the first study to look specifically at the effects of 
ractopamine on the transcriptional regulation of a contractile protein in myotube 
cultures. Our model is sufficient to evaluate the anabolic effects of ractopamine in 
porcine skeletal muscle. Unfortunately, we were unable to identify acis-acting DNA 
50 
element within the cloned Sk-a-Act that conferred transcriptional responsiveness to 
ractopamine in porcine skeletal muscle. Further evaluation of the distal regulatory 
elements in the Sk-a-Act locus and/or the 3' UTR of the gene may provide 
mechanistic detail as to how ractopamine promotes the accumulation of Sk-a-Act 
mRNA in porcine skeletal muscle. 
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Figures and Tables 
Figure 1. Agarose gel electrophoresis of amplicons generated from porcine 
myotubes by real-time quantitative PCR (10µL of PCR product per lane). Lane 1, 1-
kb ladder; lanes 2 and 3, Sk-a-Act and G3PDH amplified from ractopamine treated 
myotubes; lanes 4 and 5, Sk-a-Act and G3PDH amplified from control cultures. 
Amplification of G3PDH served as a normalization factor for comparing relative 
expression of SK-a-Act. Sizes of PCR products are indicated in basepairs (bp). 
Table 1. Detection of skeletal-a-actin mRNA in porcine myotubes as determined by 
real-time quantitative PCR. Transcript copy number was estimated from linear 
internal standards and is expressed per picogram (pg) of total RNA. Values 
represent the average of duplicate measures on the same pool of cDNA. 
Estimated Copies per pg Total RNA 





a Applied to differentiated myotubes for 72 hours in serum free media. 
b Derived from linear internal standards and normalized to glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) expression. 
`Expressed relative to time matched control. 
55 
Figure 2. Average protein concentrations in porcine myotubes. Myotubes were 
harvested after 0, 24, 48, and 72 hours in treatment media. Concentration is 
expressed as nanograms (ng) per culture. One-way ANOVA was performed within 
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Figure 3. Luciferase expression vector, which contained 2.1 kb of the porcine 
skeletal a-actin promoter. Conserved cis-acting DNA elements and transcription 
factor binding motifs are depicted (legend). Sites specific for restriction 
endonucleases used to generate truncated promoter constructs: B, BamHl ; Xb, 
Xbal ; S, Smal ; Xh, Xhol ; H, Hindl l I. 
~h B Xb S Xh I~ i t I ~ ,. .  H
2180 by 
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Figure 4. Relative luciferase activity from porcine myotubes transfected with full-
length porcine skeletal-a-actin promoter construct (pPSKA-LUC). Transfected 
myotubes were harvested after 0, 24, 48, and 72 hours in treatment media. Activity 
is expressed as relative light units (RLU) per nanogram of lysate protein. Effects: 
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LONGISSIMUS DORSI MUSCLE OF PIGS FED 
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Abstract 
Ractopamine, commercially available as Paylean, promotes hypertrophy and 
alters myosin heavy chain (MHC) isoform content in porcine skeletal muscle, 
presumably through molecular mechanisms that involve the activation of ~i- 
adrenergic receptors and associated intracellular signal transduction cascades. 
However, sufficient mechanistic detail as to how muscle hypertrophy and fiber type 
plasticity is regulated by ractopamine has proven to be elusive at the molecular 
level. We used the suppression subtractive hybridization (SSH) procedure to 
examine pre-translational gene expression after ractopamine administration in 
porcine skeletal muscle. Longissimus dorsi muscle samples were collected after 
feeding two levels of ractopamine (Paylean at 0 or 60 ppm) to maternal line pigs for 
3 d and polyadenylated (poly A+) mRNA was used to generate cDNA libraries for 
each treatment. Using the control (0 ppm) cDNA library as the driver and the 
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ractopamine (60 ppm) cDNA library as the tester, aforward-subtracted cDNA library 
was generated by SSH. After amplification by PCR, the resultant amplicons were 
subcloned and twenty-four of 192 clones were selected for sequence analysis. 
Differentially expressed genes were putatively identified by sequence homology 
(>85%) to GenBank entries. Nine genes (calmodulin-1, phosphatase inhibitor 2, 
homer homolog 1, mortalin-2, DnaJ (Hsp40) homolog, Mago-nashi homolog, 
heterogeneous nuclear ribonucleoprotein, synthrophin, and synemin) and one 
expressed sequence tag (EST) were identified as being differentially expressed in 
longissimus dorsi muscle at the pre-translational level after ractopamine stimulation. 
Northern blot analysis performed on the original RNA samples confirmed that 
calmodulin-1 mRNA abundance increases approximately 2-fold (P < 0.05) after 3 d 
of ractopamine treatment. This is the first study in which the expression of a 
calcium-modulated protein has been implicated in the phenotypic adaptations of 
skeletal muscle to ractopamine in the pig. Further elucidation of the transcriptional 
control of calmodulin-1 by ractopamine, as well as the post-translational role of this 
protein, should provide more detail as to how ractopamine alters skeletal muscle 
phenotype and enhances lean body composition. 
Keywords: ractopamine, gene expression, porcine, skeletal muscle 
Introduction 
In the pig, the ~3-adrenergic agonist ractopamine stimulates muscle 
hypertrophy (Beermann, 2002; Kim & Sainz, 1992) and increases lean carcass 
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composition (Watkins et al., 1990). Increases in protein synthetic rate (Adeola et al., 
1992; Bergen et al., 1989), changes in myosin heavy chain (MHC) isoform content 
(Depreux et al., 2002), and increases in the pre-translational expression of skeletal 
muscle specific genes (Grant et al., 1993; Helferich et al., 1990) have been 
observed in porcine skeletal muscle after feeding ractopamine. These effects 
appear to be the result of changes in many biological processes, which may include 
enzymatic activity, substrate utilization, protein synthetic rate and/or translation 
efficiency, and gene transcription. However, sufficient detail as to how ractopamine 
may directly alter these physiologically relevant processes has remained largely 
elusive at the molecular level. 
Modified gene expression accompanies phenotypic changes when skeletal 
muscle undergoes both hypertrophy (Carson, 1997; Goldspink, 2002) and atrophy 
(Bey et al., 2003; Wittwer et al., 2002). While not a prerequisite, sustained increases 
in the steady-state mRNA levels of proteins involved in ion transport, biochemical 
pathways, cellular integrity, and signal transduction pathways tend to indicate 
cellular adaptations to stimuli that promote hypertrophy as well as fiber type 
plasticity. The identification of genes that are pre-translationally regulated by 
trophic, hormonal, or mechanical stimuli provides a framework from which to develop 
innovative hypothesis-driven research, as this approach often implicates novel signal 
transduction pathways and molecular events that are not fully appreciated. The aim 
of this study was to identify genes in porcine skeletal muscle that are potentially 
regulated by ractopamine in order to further illustrate the molecular mechanisms 
involved in both skeletal muscle hypertrophy and fiber type plasticity. 
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Materials and methods 
Animals and Tissue Collection 
Longissimus dorsi muscle samples were harvested from a subset of animals 
used in a larger study previously reported (Depreux et al., 2002). Four animals per 
treatment (0 and 60 ppm Paylean) were slaughtered after 3 d. Longissimus muscle 
samples were removed and snap frozen in liquid nitrogen. All samples were stored 
at -80°C until analysis. 
RNA Isolation and Poly(A+) mRNA Synthesis 
Total RNA was isolated with the RNeasy Midi kit (Qiagen, Valencia, CA) as 
described in the manufacturer's protocol. Briefly, longissimus dorsi samples (0.25 g) 
were individually homogenized in 3.0 mL of Buffer RLT (Qiagen) with a Polytron 
homogenizer (Brinkmann Instruments, Inc., Westbury, NY). Homogenates were 
digested with Proteinase K (20 mg/mL; Qiagen) at 55°C for 20 min. After removal of 
tissue debris by centrifugation, cleared lysates were loaded onto RNeay Midi column 
and rinsed by the addition of 4.0 mL of Buffer RW1 followed by two rinses with 
Buffer RPE (2.5 mL) as described in the kit's protocol. Total RNA was eluted in two 
volumes of Rnase-free water (500 µL total) and quantified (A260). Equal amounts of 
total RNA (0.25 mg) from each animal were pooled by treatment (1.0 mg final) and 
poly A+ RNA was purified with the Oligotex mRNA kit (Qiagen) as described in the 
manufacturer's protocol. Briefly, total RNA pools were incubated in Buffer OBB (500 
µL) and Oligotex Suspension (55 µL) for 3 min at 70°C. The Oligotex:mRNA 
complexes were isolated by centrifugation, resuspended in 400 µL Buffer OW2, and 
63 
applied to small spin columns. After rinsing (400 µL of Buffer OW2), poly A+ RNA 
was eluted in 100 µL of Buffer OEB, which had been pre-warmed to 70° C. Purified 
poly A+ RNA was quantified (A260) and stored at -80°C. 
cDNA Library Synthesis 
For each treatment pool (0 ppm and 60 ppm Paylean), a cDNA library was 
generated from poly A+ RNA with the First-Strand cDNA Synthesis Kit (Amersham 
Pharmacia Biotech, Inc., Piscataway, NJ) and second-strand synthesis procedures 
outlined in the Clonetech PCR-Select cDNA Subtraction Kit (BD Biosciences 
Clontech, Palo Alto, CA). Briefly, 0.75 mg of poly A+ RNA was denatured at 65°C for 
10 min and first-strand synthesis was initiated by the addition of bulk first-strand 
reaction mix (5 µL; Amersham), 1,4-Dithio-DL-threitol (DTT; 1µL), cDNA synthesis 
primer (10µM; Clonetech), and RNAse-free water to a final volume of 20 µL. The 
reaction mixture was incubated at 37°C for 1 h. Second-strand synthesis was 
initiated by the addition of 5X second-strand buffer (16.0 µL), dNTP mix (10 mM), 
20X second-strand enzyme cocktail (4.0 µL; Clonetech), and RNAse-free water to a 
final volume of 80 µL. The reaction was incubated at 16°C for 2 h and terminated by 
the addition of 4µL of 20X EDTA/glcogen mix (0.2 M EDTA; 1 mg/mL glycogen). 
Generated cDNAs were isolated by phenol:chloroform extraction and ethanol 
precipitation as directed by the manufacturer's protocol (Clonetech). 
Suppression Subtractive Hybridization 
A polymerase chain reaction (PCR)-based cDNA suppression subtractive 
hybridization (SSH) was performed on the two generated cDNA libraries in order to 
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identify differentially expressed mRNAs in longissimus muscle of Paylean fed pigs. 
The Clonetech PCR-Select cDNA Subtraction Kit (Clontech) was used as described 
in the manufacturer's protocol. The cDNA library generated from pigs fed 60 ppm 
Paylean was designated "tester" and the cDNA library from pigs fed 0 ppm Paylean 
was designated "driver." Both cDNA libraries were digested with the restriction 
endonuclease Rsal (15 U) in 10X restriction digest buffer (New England Biolabs, 
Beverly, MA) at 37°C for 1.5 h. After phenol:chloroform extraction, tester cDNA 
populations were divided into two microcentrifuge tubes and ligated with either 
adapter 1 (10µN1) or adapter 2R (10µM) in 5X ligation buffer with T4 DNA ligase 
(400 U). Prior to overnight ligation at 16°C, 2µL of each ligation mixture was 
reserved and diluted into 1 ml sterilized water to serve as an unsubtracted control in 
later procedures. No adapter sequence was ligated to the driver (0 ppm Paylean) 
cDNA library. After the confirmation of successful adapter ligation by PCR, the first 
subtractive hybridization was performed by the addition of Rsal-digested driver 
cDNA (1.5 µL) and 4X hybridization buffer (1.0 µL; Clonetech) to microcentrifuge 
tubes that contained either 1.5 µL of adapter 1-ligated or 1.5 µL of adaptor 2R-
ligated tester cDNA. The mixture was denatured for 1.5 min at 95°C and incubated 
at 68°C for 8 h. A second hybridization was performed by simultaneously combining 
both samples and 1µL of freshly denatured driver cDNA. Hybridization was allowed 
to proceed overnight at 68°C. Subtracted samples were diluted by the addition of 
200 µL dilution buffer (20 mM HEPES pH 8.3, 50 mM NaCI, and 0.2 mM EDTA), 
heated for 10 min at 68°C, and stored at -20°C. 
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PCR amplification of Subtracted Products 
Two PCR amplifications were performed on the subtracted and unsubtracted 
products. For the primary PCR amplification, 1µL of subtracted or unsubtracted 
cDNAs was combined with 10X PCR reaction buffer (2.5 µL), dNTP mix (10 m11/>), 
PCR primer 1 (Clonetech), 50X Advantage cDNA Polymerase Mix (0.5 µL; 
Clonetech), and sterile water to a final volume of 25 µL. Polymerase chain reaction 
conditions were: 75°C for 5 min followed by 28 cycles of 94°C for 30 s, 66°C for 30 
s, 72°C for 1.5 min. Amplified PCR products were diluted ten-fold in sterile water 
and 1µL of diluted primary PCR products were combined with 10X PCR reaction 
buffer (2.5 µL}, dNTP mix (10 mM), nested PCR primer 1 (10µM; Clonetech), nested 
PCR primer 2R (10µM; Clonetech), 50X Advantage cDNA Polymerase Mix (0.5 µL; 
Clonetech). Polymerase chain reaction conditions for secondary amplification were: 
94°C for 30 s followed by 25 cycles of 68°C for 30 s and 72°C for 1.5 min. Primary 
and secondary PCR products were analyzed by gel electrophoresis (Figure 1). 
Cloning of Amplified Subtraction Products for Sequence Analysis 
Freshly amplified secondary PCR products were subcloned into pGEM-T 
Easy vector overnight at 4°C as described by the pGEM-T Easy Vector System 
protocol {Promega, Madison, WI). Ligation reactions were transformed into JM109 
High Efficiency Competent Cells (Promega) and 100 µL of each transformation was 
plated on LB/ampicillin/isopropyl-beta-D-thiogalactopyranoside (IPTG)/ 5-bromo-4- 
chloro-3-indolyl-beta-D-galactopyranoside (X-gal) plates., which were incubated at 
37°C overnight as recommended. Blue/white color screening was used to select 
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192 colonies for further analysis. Plasmid DNA was extracted and purified in a 96-
well format as previously described by Marra et al. (1997). Briefly, 1.2 mL of Terrific 
Broth II (TB; Bio 101, Inc., Carlsbad, CA) was supplemented with ampicillin (50 
mg/mL) and inoculated with a single colony. Cultures were grown in 2-mL 96-well 
blocks for 18 h at 37°C with agitation at 300 rpm in a shaking incubator. After 
growth, glycerol stocks were prepared by combining 50 µL of culture with 50 µL of 
30% glycerol in TB in 96-well microplates. Microplates were sealed and glycerol 
stocks were maintained at —80°C. Bacterial cultures were pelleted by centrifugation 
at 1730x g for 15 min at 4°C. Pellets were resuspended in 100 µL of GET/RNase 
buffer (90 mg/mL dextrose, 25 mM Tris-HCI pH 8.0, 10 mM EDTA pH 8.0, 20 mg/mL 
RNase A (Sigma Chemical Co., St. Louis, MO)) and lysed by the addition of 200 µl of 
cell lysis solution (0.2 N NaOH/ 1 % SDS} followed by agitation for 5 min at room 
temperature. The lysis reaction was terminated by the addition of 200 µL of 3 M 
potassium acetate (KAc; pH 4.8) followed by incubation at 4°C for 30 min. Cellular 
debris was pelleted by centrifugation (3000x g for 20 min at 4°C) and the cleared 
lysate was applied to UniFilter 96-well filter plates (Whatman, Inc., Clifton, NJ) in two 
aliquots of 200 µL. The UniFilter plates were then secured above UniPlate 96-well 
collection plates (Whatman) that contained 300 µL of isopropanol. The plates were 
centrifuged at 3100x gfor 80 min at 0°C to purify and precipitate plasmid DNA. 
Precipitated DNA was resuspended in 50 µL of sterile water and stored at —20°C. 
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Sequence analysis 
Prior to sequence analysis, 5µL of purified plasmid DNA was digested 
overnight with the restriction endonuclease EcoRl at 37°C in a reaction that 
contained 10X reaction buffer (Promega), acetylated bovine serum albumin (BSA; 
0.1 mg/mL), EcoRl (3 U; Promega), and sterilized water to a final volume of 10µL. 
Digestion products were size separated and visualized by gel electrophoresis (1 
agarose). As the cloning vector used in this study (pGEM) contains two EcoRl 
restriction sites that flank the multiple cloning site, this step allowed for the rapid 
identification and selection of multiple cDNA inserts of various sizes for sequence 
analysis. Twenty=four unique clones were selected and 15µL of purified plasmid 
DNA was sequenced on an ABI 377 sequencer (Applied Biosystems, Inc., Foster 
City, CA) at the Iowa State University DNA Sequencing Facility with SP6 (5' GAT- 
TTA-GGT-GAC-ACT-ATA-G 3') primer. Clone identity was predicted by BLAST 
analysis and putative identification was assigned to clones that had >_ 85% homology 
to a known gene, homologue, or expressed sequence tag (EST). Cloned sequences 
were also compared to porcine-specific (Sus scrofa) EST clones deposited in 
GenBank. Tentative consensus (TC) sequence identity was assigned after 
comparison with the Institutive for Genomic Research (TIGR) Porcine Gene Index 
(SsGI) database. 
Confirmation of Differential Expression by Northern Blot Analysis 
The differential expression of genes recognized to be involved in signal 
transduction networks was confirmed by Northern blot analysis. Total RNA was 
collected from 0.5 g of the original longissimus dorsi samples using TRlzol reagent 
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(Invitrogen Corporation, Carlsbad, CA) as directed by the manufacturer's supplied 
protocol. Total RNA (20 µg) from each individual pig and from the two treatment 
pools identical to that used for SSH was size separated by electrophoresis through a 
1 % agarose denaturing formaldehyde gel (Ambion, Inc., Austin, TX). RNA was 
transferred to a positively charged nylon membrane (BrightStar-Plus; Ambion) and 
UV cross-linked (120,000 µJoules; Stratalinker 2400, Stratagene, La Jolla, CA). 
Riboprobes were generated with the Strip-Ez kit (Ambion). The differential 
expression of calmodulin-1 was confirmed with an antisense complementary RNA 
(cRNA) probe synthesized from a sequenced clone, designated pGEM-CaM1, which 
was 87% homologus to the 3' untranslated region of the human calmodulin-1 mRNA 
sequence (GenBank Accession No. U16850). Briefly, 1µg of pGEM-CaM1 was 
linearized by restriction digest with Dralll (Promega) and gel purified (Qiagen Gel 
Extraction Kit). Linearized plasmid DNA (50 ng) was incubated at 40°C for 2 h in a 
reaction that contained 10X transcription buffer (Ambion), ATP (5 mlVn, CTP (5 mll~, 
GTP (5 mIV/j, 800 Ci/mmol [a-32P] UTP (3.125 µll~, T7 RNA polymerase mix (10 U; 
Ambion), and Rnase-free water to a final volume of 20 µL. After digestion with 
Rnase-free DNase I (10 U; 37°C for 15 min) and column purification (Bio-spin 
column; Bio-Rad Corp, Hercules, CA), the synthesized cRNA probe was hybridized 
to the Northern blot overnight at 68°C with agitation in 30 mL of Ultra-Hyb buffer 
(Ambion). The membrane was washed once in Low Stringency Wash Solution #1 
(Ambion Northern Max Kit) for 5 min with agitation at room temperature and two 
consecutive times with High Stringency Was Solution #2 for 15 min at 68°C. The 
hybridization signals were obtained using by exposing the hybridized blot to a 
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Phosphorlmager screen at room temperature for 24 h and scanning the screen with 
a Molecular Dynamics Storm 860 Phosphorlmager System (Amersham). 
Hybridization signals were quantified with version 1.2 of ImageQuant for Macintosh 
(Amersham). Values were corrected against the R-actin signal obtained from cRNA 
probes generated with the pTRl-~3-actin-Mouse template DNA supplied in the Strip- 
EZ kit as recommended by the manufacturer. Riboprobes were synthesized for 
phosphatase inhibitor 2 and homer homolog 1 b in a similar manner, but the resultant 
hybridization signal was below detection threshold by Northern blot analysis. 
Statistical Analysis 
Densitometry data was analyzed by one-way analysis of variance (ANOVA) 
with JMP software (Release 5.0, 2001; SAS Institute Inc., Cary, NC). Least squares 
means and the standard error of the mean are reported. Comparisons were 
significantly different at the level of P < 0.05. 
Results and Discussion 
While phenotypic changes (muscle hypertrophy and fiber type plasticity) in 
skeletal muscle are well documented (Beermann, 2002; Kim & Sainz, 1992), little is 
known about the global changes in gene expression that occur after the 
administration of R-adrenergic agonists to livestock species. In the post-genomic 
era, the use of cDNA microarray analysis to facilitate gene expression profiling and 
discovery has provided insight into the genetic regulation of muscle adaptation in 
animal models of resistance training (Carson et al., 2002), muscle wasting (Wittwer 
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et al., 2002), muscular dystrophy (Haslett &Kunkel, 2002), and aging (Weindruch et 
al., 2001). Unfortunately, high-density cDNA microarrays have been slow to reach 
the laboratories of animal scientists and, only recently, has a porcine skeletal muscle 
cDNA microarray been developed and publicly reported (Bai et al., 2003; Yao et al., 
2002). This study used an alternative method, suppression subtractive hybridization 
(SSH), to identify differentially regulated genes in the longissimus dorsi muscle of 
ractopamine treated pigs after 3 d of treatment. This technique allows for the 
selective enrichment of lowly expressed genes from a normalized cDNA library 
(Diatchenko et al., 1996). We were able to putatively identify nine previously 
unreported genes and one EST, which may be differentially expressed in skeletal 
muscle after stimulation with ractopamine. 
In this study, SSH was performed on cDNA libraries generated from a subset 
of muscle samples collected for a larger study, which investigated myosin heavy 
chain (MHC) isoform abundance in skeletal muscle after feeding three levels of 
ractopamine (0, 20, or 60 ppm Paylean) to pigs for 3, 7, 14, 28, or 42 d (Depreux et 
al., 2002). We chose to use the longissimus dorsi muscle samples collected after 3 
d from two treatment doses (0 and 60 ppm). Previously, pigs fed 60-ppm 
ractopamine grew faster (average daily gain) and had a relatively higher abundance 
of 2A MHC fibers in longissimus dorsi and semitendinosus muscles when compared 
to contemporary controls after 3 d (Depreux et al., 2002). Additionally, previous 
reports have indicated that the longissimus muscle is susceptible to hypertrophy, 
and increases in mass in response to ractopamine (Adeola et al., 1990; Stites et al., 
1991; Yen et al., 1991). We hypothesized that differentially expressed genes 
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identified in porcine longissimus muscle after 3 d of ractopamine administration 
would be involved in the stimulation and/or the maintenance of muscle growth and 
fiber type plasticity. 
We used poly A+ mRNA to generate cDNA libraries to represent each 
treatment pool. After hybridization and PCR, the transcript size of the differentially 
expressed (forward-subtracted) cDNAs was analyzed by gel electrophoresis (Figure 
1). Amplicon size ranged from approximately 200 to 1500 base pairs (bp), with three 
abundant amplicons, relative to the unsubtracted cDNA pool, visualized between 
396 and 750 bp. Amplicons were subcloned, sequenced, and assigned putative 
gene identification after BLAST analysis. 
Of the 24 clones sequenced, we were able to identify 22 by sequence 
comparison; poor sequencing reaction results prohibited the identification of two 
clones. Nine genes and one EST were identified as being potentially differentially 
expressed by SSH (Table 1). With the exception of one clone with low homology 
(82%) to synemin, isoform B, the sequenced clones were >_ 85% homologus to 
known sequences deposited in GenBank. We observed several instances of 
redundancy between cDNA clones; in total, 12 of the 22 clones compared by 
sequence analysis shared homology with the same GenBank entry for four different 
genes (calmodulin-1 (3), phosphatase inhibitor 2 (4), DnaJ (Hsp40) homolog (3), and 
syntrophin (2)). The nine genes and one EST were categorized into functional 
clusters (Table 1) before further analysis. Sequenced cDNA clones were also 
compared with porcine EST sequences deposited into GenBank and were assigned 
a TC identity (Table 2). The putatively identified genes encode two structural 
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proteins, two chaperon proteins, two mRNA processing proteins, and three proteins 
that have been implicated in signal transduction pathways. We chose to confirm the 
differential expression of the one gene involved in the maintenance of calcium 
homeostasis and signal transduction pathways, calmodulin-1 (CALM1), in order to 
further elucidate the molecular mechanisms by which ractopamine affects muscle 
phenotype. 
Northern blot analysis confirmed the differential expression of CALM1 in 
ractopamine treated skeletal muscle after 3 d (Figure 2A). After normalization to ~i- 
actin steady-state mRNA abundance, CALM1 mRNA levels increased approximately 
2-fold in both the pooled ractopamine sample and when the densitometry values 
obtained from each individual animal were averaged (P < 0.05), relative to the 
mRNA levels in untreated longissimus muscle (Figure 2B). Interestingly, CALM1 
expression increased in three of the four pigs fed ractopamine; it is unclear why one 
individual did not respond to the treatment (lane 6 in Figures 2A and 2B). These 
results, together with the fact that six cDNA clones had high homology to CALM1 
mRNA transcripts in both the human and the rat (Table 1), suggest that CALM1 may 
be regulated pre-translationally by ractopamine and that the encoded protein product 
may play an important role in ractopamine-induced skeletal muscle hypertrophy and 
fiber type plasticity. 
Calmodulin (CaM) is a ubiquitously expressed calcium-modulating protein 
and has been implicated in both skeletal muscle hypertrophy and MHC isoform 
transitions through the activation and regulation of the Ca+/CaM-dependent protein 
phosphatase, calcineurin (CaN), and Ca+/CaM-dependent kinases (CaMKs) (Naya 
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et al., 2000; Olson &Williams, 2000b; Semsarian et al., 1999). In C2C12 mouse 
myotubes, activated (Ca+/CaM-bound) CaN and CaMKII are required for 2A MHC 
promoter activity in response to calcium ionophore treatment (Allen &Leinwand, 
2002). Activated CaN and CaMKII regulate two families of transcription factors, 
myocyte-specific enhancer factor 2 (MEF2) and nuclear factor/activator of T cells 
(NEAT), both of which are necessary to increase 2A MHC promoter activity (Allen & 
Leinwand, 2002; Allen et al., 2001). Additionally, CaN induces gene expression 
during skeletal muscle hypertrophy through the promotion of NEAT interactions with 
the transcription factor GATA2 at promoter sequences (Olson &Williams, 2000a). 
Ca+/CaM-dependent kinases also provide transcriptional control of gene expression 
(Corcoran &Means, 2001; Shimomura et al., 1996). Histone deacetylases (HDACs) 
interact with MEF2 to silence gene expression by histone condensation. Ca+/CaM-
dependent kinases phosphorylate serine residues in HDAC-4 and HDAC-5, which 
disrupts the MEF2:HDAC complex and restores gene expression (McKinsey et al., 
2000; Olson &Williams, 2000a). Taken together with the novel finding that 
ractopamine stimulates the accumulation of CALM1 mRNA (this study), we 
hypothesize that ~i-adrenergic agonists transcriptionally activate CaM, which, in the 
presence of increased calcium flux, positively augments CaN and CaMK activity and 
muscle specific gene expression. 
In porcine skeletal muscle, this may explain, in part, the changes in fiber type 
and contractile gene expression documented after ractopamine stimulation. The 
study conducted by Depreux et al. (2002) certainly supports this model, as the 2A 
MHC isoform was the only MHC isoform to increase in relative abundance after 
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ractopamine treatment for 3 d. This affect was lost after prolonged treatment, and 
2B MHC became the predominant isoform expressed in skeletal muscle. 
Interestingly, CALM 1 is also differentially expressed in mouse quadriceps relative to 
the soleus muscle (Campbell et al., 2001), which suggests a role for CaM in the 
maintenance of the fast twitch fiber phenotype. As high doses of ractopamine 
promotes the transition in MHC isoforms from 2A —~ 2AX -~ 2B in atime-dependent 
manner (Depreux et al., 2002), it is likely that CALM 1 expression remains elevated 
in response to ~i-adrenergic stimulation in order to maintain fiber type plasticity. 
Prolonged elevations in CALM 1 expression may also be involved in the 
transcriptional control of muscle hypertrophy. Skeletal a-actin mRNA abundance in 
pigs (Grant et al., 1993; Helferich et al., 1990; Liu et al., 1994) and steers (Smith et 
al., 1989) increases in response to ractopamine without a general increase in total 
muscle mRNA. Importantly, the porcine skeletal a-actin promoter contains a MEF2 
DNA element (Reecy et al., 1996), as do many muscle specific genes (Brand, 1997). 
As it now appears that CALM 1 expression precedes changes in skeletal muscle 
phenotype after ~i-adrenergic stimulation (this study), CaMK activity and the 
regulation of MEF2:HDAC complexes at the skeletal a-actin promoter in response to 
ractopamine may also provide more mechanistic detail as to how ~i-adrenergic 
agonists stimulate skeletal muscle hypertrophy at the molecular level. 
While transcriptional regulation by CaM-dependent mechanisms is certainly 
interesting and may explain the nuclear regulation of cellular phenotype in response 
to ~i-adrenergic agonists, the ubiquitous nature of calmodulin should not be 
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overlooked in future studies. In addition to CaN and CaMKs, CaM may also regulate 
the function of cellular proteins expressed in skeletal muscle. calmodulin also has 
affinity for, and regulates the function of, the ryanodine-receptor (RyR), the inositol 
1,4,5-trisphosphate type 1 receptor (InsP3R), myosin light chain kinase (MLCK), 
plasma membrane Ca-ATPase, nitric oxide synthase (NOS}, and adenylyl cyclases 
(Maier & Bers, 2002). Clearly, aractopamine-induced induction of CALM 1 
expression to the magnitude (2-fold) suggested in this study may have far reaching 
cellular consequences. 
The maintenance of calcium homeostasis within the muscle cell is vital to 
function. Multiple stimuli may converge on the ryanodine and dihydropyridine 
receptors to regulate calcium release from the sarcoplasmic reticulum (Wrzosek, 
2000). As apocalmodulin (calcium-free CaM) has been demonstrated to be an 
effective agonist of skeletal muscle RyR function {Fruen et al., 2003; Tang et al., 
2002), calmodulin-1 expression may stimulate intracellular calcium release in 
ractopamine-stimulated skeletal muscle, independent of increased calcium flux, to 
maintain or restore intracellular calcium homeostasis. 
Implications 
This is the first study to investigate differential gene expression in skeletal 
muscle after feeding ractopamine to pigs. After three days of treatment, we 
identified and confirmed the expression of the EF-hand calcium binding protein, 
calmodulin. Further analysis of the expression profile of calmodulin at multiple post-
treatment time points, as well as the post-translational role of the encoded protein, 
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should further define the nature and role of elevated calmodulin expression in 
response to ractopamine. Nonetheless, this is the first study to indirectly implicate 
calcium-modulating proteins as potentially critical participants in signal transduction 
networks and cellular homeostasis in response to ractopamine in porcine skeletal 
muscle. 
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Figures and Tables 
Figure 1. Analysis of amplified subtraction products by gel electrophoresis. 
Amplicons generated after 25 cycles of PCR from subtracted (lane 1) and 
unsubtracted (lane 2) cDNA libraries as described in Materials and Methods. CDNA 











Table 1. Differentially expressed genes in porcine longissimus dorsi muscle after 3 
days of ractopamine treatment as identified by suppression subtractive hybridization 
and BLAST analysis. 
Putative Identification a Accession No. d Homology (bp) 
Calcium-modulating proteins 
Calmodulin-1 (phosphorylase kinase, BC047523 90% (274/304)- Human 
U 16850- (3X) 90% (131 /144)- Human 
N M 031969 87% (191 /219)- Rat 
AF178845 86% (204/235)- Rat 
Homer homolog 1 (Drosophila) AF093262 95% (396/385)- Human 
Si_gna/ Transduction/ Chaperon Proteins 
Similar to protein phosphatase 1, XM 018216- (4X) 88% (289/327)- Human 
Heat shock 70kDa protein 9B (mortalin-2) BCO24034 90% (546/601)- Human 
Similar to DnaJ (Hsp40) homolog, BC033159- (3X) 86% (143/165)- Human 
mRNA Processin_q Proteins 
Mago-nashi homolog, proliferation- AF067173 94% (290/308)- Human 
Heterogeneous nuclear ribonucleoprotein BC007392 91 % (142/155)- Human 
Structural Proteins 
Syntrophin, beta 1 NM 021021- (2X) 88% (1271143)- Human 
Synemin, isoform B AJ310522 82% (106/128)- Human 
Expressed Sequence Tags 
384525 MARC 2PIG Sus scrofa cDNA 5' 81359811 °' 99% (339/341)- Pig 
a Putative identity was assigned by sequence homology after BLAST analysis. Two cDNA clones b ould not be identified due to poor sequence reaction results. 
GenBank Accession number. Multiple clones (number indicated in parenthesis) with homology 
to indicated GenBank entry. 
Percent homology of sequenced cDNA clone to GenBank entry. The number of matching base 
pair identities and species is indicated. 
Library constructed from pooled tissue from testis, ovary, endometrium, hypothalamus, pituitary, 
and placenta. Included in Table 2. 
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Table 2. Porcine-specific tentative consensus (TC) and singleton expressed 












Homology Accession EST 
(bp) b No. ~ Name d 
99% AW 620097 861 
(338/339) 




100% CB478983 Jns44 C04.f 
(216/216) 






100% B U 946720 
(192/192) 







Source e Identity f
Day 12 Singleton 
embryo 
Muscle TC 66852 






BF708768 MI-P-AYO-nai-g- Placenta 
09-0-UI.s1 
PS24U-210 Skin 
C94948 Back fat 







Pooled TC 76532 
a Putative identity was assigned by sequence homology after BLAST analysis. Refer to Table 1. 
b Percent homology of sequenced cDNA clone to GenBank entry. 
GenBank Accession number. 
°' Identity of EST sequence. 
f Tissue from which EST was generated. Tentative porcine consensus sequence identifier. TIGR Porcine Gene Index (SsGI), Vernon 
6.0, Release Date -April 30, 2003. http://www.tigr.org/tdb/tgi/ssgi/ 
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Figure 2A. Northern blot analysis to confirm differential expression of calmodulin-1 
(CALM1) in longissimus dorsi muscle samples from pigs fed two levels of Paylean (0 
ppm or 60 ppm) for 3 days. Autoradiographs of a Northern blot probed for CALM1 
(upper) and ~-Actin (lower) steady state mRNA as described in the Materials and 
Methods section. Lanes 1-4: individual animals fed 0 ppm Paylean; Lanes 5-8: 
individual animals fed 60 ppm Paylean; Lane 9: pooled RNA samples from pigs fed 
0 ppm Paylean (-); Lane 10: pooled RNA samples from pigs fed 60 ppm Paylean (+). 
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Figure 2B. Graphical summary of Northern analysis to confirm differential 
expression of CALM1 in longissimus dorsi muscle samples from pigs fed two levels 
of Paylean (0 ppm or 60 ppm) for 3 days (Figure 2A). Values are the signal intensity 
ratio of CALM1:(3-Actin steady-state mRNA relative to the 0 ppm pooled RNA values. 
Fold change from base line (0 ppm) is indicated. 
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CHAPTER 4. GENERAL CONCLUSIONS 
The livestock industry has exploited the anabolic enhancing capacity of 
growth promotants, such as antimicrobials, growth factor analogues, and R- 
adrenergic agonists, to improve production efficiency and output of nutritious meat 
products. In particular, ~i-adrenergic agonists improve lean carcass composition, 
dressing percentage, growth rate, and growth efficiency without adversely affecting 
meat quality in most species. One synthetic ~i-adrenergic agonist, ractopamine, has 
a profound effect on skeletal muscle mass in the pig. However, sufficient detail as to 
how ractopamine directly modifies skeletal muscle phenotype has remained elusive. 
The further elucidation of ractopamine's mode of action in skeletal muscle 
may enhance the utility of future growth promotants in livestock production systems. 
For example, if ractopamine does indeed utilize a unique molecular mechanism to 
direct muscle growth, the identification of that mechanism would be beneficial to the 
development of targeted growth promotants that augment the pathway more 
effectively. The R-adrenergic receptor is subject to constant regulation by both 
desensitization and transcriptional down-regulation. If downstream signal 
transduction proteins involved in the transmission of this stimulus (ractopamine) are 
identified, it is conceivable that pharmacological agonists could be utilized to activate 
these proteins independent of the ~i-adrenergic receptor. Such an approach would 
effectively by-pass the celPs intrinsic ability to desensitize the ~i-adrenergic receptor, 
which may lead to a constitutively activated system and further enhancement in the 
rate of protein accretion and muscle hypertrophy. 
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Alternatively, the. identification of the critical proteins involved in the 
intracellular signal transduction pathways) activated by ~i-adrenergic agonists, and 
the selective activation of these proteins, could benefit the field of human medicine, 
particularly in the prevention and/or treatment of cachexia and muscular dystrophies. 
As ~i-adrenergic stimulation is closely coupled with cardiac contractility and 
hypertrophy, potential cardiovascular complications preclude the use ~i-adrenergic 
agonists to spare skeletal muscle mass from severe atrophy and loss of function in a 
clinical setting. Hypothetically, if the molecular mechanisms that underlie skeletal 
muscle hypertrophy in response to ~3-adrenergic agonists are distinct from those 
present in cardiac muscle, effective pharmaceutical intervention and/or gene therapy 
becomes reasonable. This is especially true if the difference in the two pathways is 
subtle. For example, the hypertrophic response in skeletal muscle may require one 
protein isoform whereas the cardiac-specific pathway may utilize a splice variant of 
that same protein or an isoform encoded by a different gene. In the post-genomic 
era, our ability to systematically dissect the biochemical and molecular pathways 
that trigger physiological responses is greatly enhanced, which allows for exploration 
of questions that were once thought to be unanswerable. 
This project investigated the effect of ractopamine on gene regulation in 
skeletal muscle in the pig. In the first study, the hypothesis that ractopamine directly 
regulates the expression of the porcine skeletal a-actin gene via cis-acting DNA 
elements was tested. ~i-Adrenergic agonists stimulate the accumulation of skeletal 
a-actin mRNA without a global augmentation of total RNA synthesis. This increase 
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in pre-translational expression parallels increases in myofibrillar protein expression 
and skeletal muscle hypertrophy in porcine skeletal muscle that has been stimulated 
with ractopamine. Therefore, identifying regulatory mechanisms that control the 
expression of this specific gene should provide insight into the mechanisms by which 
ractopamine induces skeletal muscle hypertrophy. 
We developed an in vitro model that was sufficient to recapitulate the 
increased pre-translational expression of skeletal a-actin to test our hypothesis. 
However, we were unable to identify aractopamine-responsive DNA regulatory 
element within the full-length porcine skeletal a-actin promoter. From our data, we 
concluded that either another regulatory mechanism within the porcine skeletal a-
actin locus contributes to the transcriptional regulation of this gene, or _that mRNA 
stability is in some way altered after ractopamine-stimulation. Both mechanisms 
may be valid explanations for the observed increase in skeletal a-actin mRNA 
abundance in pigs treated with ractopamine and warrant empirical investigation. 
In a second study, we identified differentially expressed .genes by suppression 
subtractive hybridization. With this technique, a cDNA library is normalized and 
differentially expressed genes are enriched and identified. Presumably, these genes 
are regulated by ractopamine and/or are required for sustained muscle hypertrophy 
and fiber type plasticity. 
We identified nine genes and one expressed sequence tag that are possibly 
regulated in response to ractopamine in porcine skeletal muscle. This work revealed 
that ractopamine positively augments the expression of calmodulin-1 and is the first 
such study to indirectly implicate calcium-modulating proteins as potentially critical 
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participants. in signal transduction networks and/or cellular homeostasis. in response 
to ~i-adrenergic agonists. Calcium, calmodulin, and calmodulin-dependent proteins 
have been demonstrated to be potent regulators of skeletal muscle hypertrophy and 
muscle fiber phenotype. Further analysis of the expression profile of both CALM1 
and homer-1 b at multiple post-treatment time points should further define the nature 
of their expression in response to ~i-adrenergic agonists. 
In summary, the research described herein has provided insight into the 
molecular events that underlie skeletal muscle adaptation to ~i-adrenergic 
stimulation. In no way has this been an all-inclusive study, but it has underscored 
the complexity of protein-protein interactions that convey responsiveness to 
ractopamine within the myofiber. Certainly, increased production of cyclic adenosine 
monophosphate (CAMP) is a well documented cellular response to ~i-adrenergic 
receptor activation, but other second messengers, such as calcium, may be more 
intimately involved in the regulation of gene expression and skeletal muscle 
hypertrophy. Future work must use molecular techniques beyond the simplistic 
_measure of cellular CAMP concentration to delineate the intracellular signal 
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